{"content":"<li class=\"n-box-item date-title\" data-end=\"1575521999\" data-start=\"1575435600\" data-txt=\"Monday, December 23, 2019\">Wednesday, December  4, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3523879\" data-ts=\"1575503879\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MLND\" target=\"_blank\">MLND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523879-millendominus-19-offering-said-to-come-22_7-discount\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Millendo -19% with offering said to come at 22.7% discount</a></h4><ul>   <li>Millendo Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MLND' title='Millendo Therapeutics, Inc.'>MLND</a>) is <font color=\"red\">down 18.8%</font> in light postmarket trade after its <a href=\"https://seekingalpha.com/news/3523800-millendo-therapeutics-readies-equity-offering\" target=\"_blank\">proposed equity offering</a> is said to amount to $25M in shares.</li>    <li>Those shares are expected to come at $6 each, Bloomberg reports - a 22.7% discount from today's close.</li>    <li>The offering comes via Citi and SVB Leerink.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3523879\" data-linked=\"Millendo -19% with offering said to come at 22.7% discount\" data-tweet=\"$MLND - Millendo -19% with offering said to come at 22.7% discount https://seekingalpha.com/news/3523879-millendominus-19-offering-said-to-come-22_7-discount?source=tweet\" data-url=\"https://seekingalpha.com/news/3523879-millendominus-19-offering-said-to-come-22_7-discount\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523876\" data-ts=\"1575502844\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GDS\" target=\"_blank\">GDS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523876-gdsminus-1_7-on-250m-ads-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GDS -1.7% on $250M ADS offering</a></h4><ul>   <li>GDS Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/GDS' title='GDS Holdings Limited'>GDS</a>) is <font color=\"red\">1.7% lower</font> after hours following news that it will offer and sell about <a href=\"https://seekingalpha.com/pr/17718840-gds-announces-launch-of-proposed-public-offering-of-adss\" target=\"_blank\">$250M in American Depositary Shares</a>.</li>    <li>Each ADS represents eight of the company's class A ordinary shares.</li>    <li>Underwriters will get a 30-day greenshoe option to buy about $37.5M more.</li>    <li>The company intends to use about $190M of the net proceeds to help fund acquisition of three data centers in the Shunyi district of Beijing.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3523876\" data-linked=\"GDS -1.7% on $250M ADS offering\" data-tweet=\"$GDS - GDS -1.7% on $250M ADS offering https://seekingalpha.com/news/3523876-gdsminus-1_7-on-250m-ads-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3523876-gdsminus-1_7-on-250m-ads-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523874\" data-ts=\"1575502111\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WHF\" target=\"_blank\">WHF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523874-whitehorse-financeminus-1_8-amid-reported-holder-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WhiteHorse Finance -1.8% amid reported holder offering</a></h4><ul>   <li>WhiteHorse Finance (NASDAQ:<a href='https://seekingalpha.com/symbol/WHF' title='WhiteHorse Finance'>WHF</a>) is <font color=\"red\">down 1.8%</font> postmarket after Bloomberg reports that holder HIG Capital is offering $30M in shares.</li>    <li>That offering is to come at $13.83/share, according to the report. <a href='https://seekingalpha.com/symbol/WHF' title='WhiteHorse Finance'>WHF</a> closed today at $14.25, meaning a 3% discount.</li>    <li>It comes via Raymond James, Keefe Bruyette &amp; Woods, Deutsche Bank Securities, Ladenburg Thalmann, Oppenheimer, B. Riley, and National Securities.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3523874\" data-linked=\"WhiteHorse Finance -1.8% amid reported holder offering\" data-tweet=\"$WHF - WhiteHorse Finance -1.8% amid reported holder offering https://seekingalpha.com/news/3523874-whitehorse-financeminus-1_8-amid-reported-holder-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3523874-whitehorse-financeminus-1_8-amid-reported-holder-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:28 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523871\" data-ts=\"1575501468\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AXE\" target=\"_blank\">AXE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523871-anixterplus-2_9-filing-shows-received-90-share-offer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Anixter +2.9% as filing shows it received $90/share offer</a></h4><ul>   <li>Anixter (NYSE:<a href='https://seekingalpha.com/symbol/AXE' title='Anixter International Inc.'>AXE</a>) is <font color=\"green\">up 2.9%</font> after hours following a <a href=\"https://seekingalpha.com/filing/4724799\" target=\"_blank\">filing</a> disclosing that an unidentified bidder has offered $90/share for the company.</li>    <li>On Nov. 16, a bidder listed as \"Party A\" submitted a revised takeover proposal valued at $90/share - 45% in cash, and 55% of newly issued Party A shares.</li>    <li>The proxy statement details a timeline since then of meetings and discussions around acquiring the company.</li>    <li>Anixter closed today at $85.51.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3523871\" data-linked=\"Anixter +2.9% as filing shows it received $90/share offer\" data-tweet=\"$AXE - Anixter +2.9% as filing shows it received $90/share offer https://seekingalpha.com/news/3523871-anixterplus-2_9-filing-shows-received-90-share-offer?source=tweet\" data-url=\"https://seekingalpha.com/news/3523871-anixterplus-2_9-filing-shows-received-90-share-offer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:17 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523867\" data-ts=\"1575500221\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EVRI\" target=\"_blank\">EVRI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523867-everiminus-3-after-launching-10m-share-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Everi -3% after launching 10M-share offering</a></h4><ul>   <li>Everi Holdings (NYSE:<a href='https://seekingalpha.com/symbol/EVRI' title='Everi Holdings Inc.'>EVRI</a>) is <font color=\"red\">down 3%</font> after hours following the launch of a public <a href=\"https://seekingalpha.com/pr/17718749-everi-announces-commencement-of-public-offering-of-common-stock\" target=\"_blank\">offering of common stock</a>.</li>    <li>The company's started an underwritten offering of 10M shares.</li>    <li>It's granting underwriters a 30-day greenshoe option to buy up to an additional 1.5M shares.</li>    <li>Net proceeds will go toward refinancing existing indebtedness, which could include repurchasing part of its outstanding 7.5% senior unsecured notes due 2025.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3523867\" data-linked=\"Everi -3% after launching 10M-share offering\" data-tweet=\"$EVRI - Everi -3% after launching 10M-share offering https://seekingalpha.com/news/3523867-everiminus-3-after-launching-10m-share-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3523867-everiminus-3-after-launching-10m-share-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523865\" data-ts=\"1575499720\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SESN\" target=\"_blank\">SESN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523865-sesenplus-9_2-after-successful-pre-bla-fda-meeting\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sesen +9.2% after successful pre-BLA FDA meeting</a></h4><ul>   <li>Sesen Bio (NASDAQ:<a href='https://seekingalpha.com/symbol/SESN' title='Sesen Bio, Inc.'>SESN</a>) is <font color=\"green\">up 9.2%</font> postmarket after reporting a successful Chemistry, Manufacturing and Controls <a href=\"https://seekingalpha.com/pr/17718819-sesen-bio-completes-successful-cmc-type-b-pre-bla-meeting-fda\" target=\"_blank\">meeting with the FDA</a> over Vicinium.</li>    <li>That comes as a step before the company's Biologics License Application; the company now expects to initiate its BLA submission this month.</li>    <li>The company and agency came to agreement on the BLA content and the FDA hasn't requested further meetings, Sesen says.</li>    <li>\u201cAfter four highly collaborative and productive meetings with the FDA in 2019, we feel increasingly confident in the regulatory path forward for Vicinium,\u201d says CEO Dr. Thomas Cannell.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3523865\" data-linked=\"Sesen +9.2% after successful pre-BLA FDA meeting\" data-tweet=\"$SESN - Sesen +9.2% after successful pre-BLA FDA meeting https://seekingalpha.com/news/3523865-sesenplus-9_2-after-successful-pre-bla-fda-meeting?source=tweet\" data-url=\"https://seekingalpha.com/news/3523865-sesenplus-9_2-after-successful-pre-bla-fda-meeting\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523864\" data-ts=\"1575499270\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HHC\" target=\"_blank\">HHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523864-howard-hughesplus-5-on-pershing-square-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Howard Hughes +5% on Pershing Square stake</a></h4><ul>   <li>Howard Hughes (NYSE:<a href='https://seekingalpha.com/symbol/HHC' title='The Howard Hughes Corporation'>HHC</a>) is <font color=\"green\">up 5%</font> postmarket after Pershing Square reports a stake of 14.8%.</li>    <li>It filed a <a href=\"https://seekingalpha.com/filing/4724565\" target=\"_blank\">Form 4</a> covering the purchase of common stock, the termination of swaps, the purchase of forward contracts and ordinary course rebalancing transactions.</li>    <li>Those were all effected at the same time on Dec. 2, according to the filing.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3523864\" data-linked=\"Howard Hughes +5% on Pershing Square stake\" data-tweet=\"$HHC - Howard Hughes +5% on Pershing Square stake https://seekingalpha.com/news/3523864-howard-hughesplus-5-on-pershing-square-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/3523864-howard-hughesplus-5-on-pershing-square-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523854\" data-ts=\"1575497095\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VRNT\" target=\"_blank\">VRNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523854-verintplus-17-after-separation-plans-300m-buyback\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Verint +17% after separation plans, $300M buyback</a></h4><ul><li>Verint Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/VRNT' title='Verint Systems Inc.'>VRNT</a>) <font color=\"green\">gains 17%</font> after the company <a href=\"https://seekingalpha.com/pr/17718719-verint-announces-plan-to-separate-two-independent-publicly-traded-companies\" target=\"_blank\">announces</a> plans to separate into to independent public companies after the next fiscal year ends on January 31, 2021.</li><li>One business will consist of the customer engagement business and the other the cyber intelligence business.</li><li>Verint also announces that funds advised by Apax Partners will invest $400M into the company.</li><li>The board authorizes a new $300M buyback authorization that expires on February 1, 2021.</li><li>The flurry of news arrived with the company's <a href=\"https://seekingalpha.com/news/3523801-verint-systems-eps-beats-0_09-misses-on-revenue\" target=\"_blank\">Q3 report</a>, which beat on EPS but missed on revenue.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523854\" data-linked=\"Verint +17% after separation plans, $300M buyback\" data-tweet=\"$VRNT - Verint +17% after separation plans, $300M buyback https://seekingalpha.com/news/3523854-verintplus-17-after-separation-plans-300m-buyback?source=tweet\" data-url=\"https://seekingalpha.com/news/3523854-verintplus-17-after-separation-plans-300m-buyback\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523848\" data-ts=\"1575496849\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARDX\" target=\"_blank\">ARDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523848-ardelyx-launches-80m-stock-offering-shares-down-1-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ardelyx launches $80M stock offering; shares down 1% after hours</a></h4><ul><li>Ardelyx (NASDAQ:<a href='https://seekingalpha.com/symbol/ARDX' title='Ardelyx, Inc.'>ARDX</a>) <a href=\"https://seekingalpha.com/pr/17718850-ardelyx-announces-proposed-public-offering-of-common-stock\" target=\"_blank\">commences </a>an $80M public offering of common stock. Underwriters' over-allotment will be an additional $12M of stock. Price, volume and terms have yet to be announced.</li><li>Shares down <font color=\"red\">1%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523848\" data-linked=\"Ardelyx launches $80M stock offering; shares down 1% after hours\" data-tweet=\"$ARDX - Ardelyx launches $80M stock offering; shares down 1% after hours https://seekingalpha.com/news/3523848-ardelyx-launches-80m-stock-offering-shares-down-1-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3523848-ardelyx-launches-80m-stock-offering-shares-down-1-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523845\" data-ts=\"1575496696\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NJR\" target=\"_blank\">NJR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523845-new-jersey-resources-launches-235m-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New Jersey Resources launches $235M stock offering</a></h4><ul><li>New Jersey Resources (NYSE:<a href='https://seekingalpha.com/symbol/NJR' title='New Jersey Resources Corporation'>NJR</a>) <font color=\"red\">-4.8%</font> after-hours on news it commenced a <a href=\"https://seekingalpha.com/pr/17718827-njr-announces-public-offering-of-common-stock\" target=\"_blank\">public offering</a> of $235M of common shares, with an underwriters option to purchase as much as $35M of additional shares.</li><li>NJR plans to use the proceeds from the offering and the settlement of forward sale agreements to repay part of the borrowings under the bridge credit facility put in place  to finance its Leaf River Energy Center acquisition and  for general corporate purposes.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523845\" data-linked=\"New Jersey Resources launches $235M stock offering\" data-tweet=\"$NJR - New Jersey Resources launches $235M stock offering https://seekingalpha.com/news/3523845-new-jersey-resources-launches-235m-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3523845-new-jersey-resources-launches-235m-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523842\" data-ts=\"1575496011\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ESTC\" target=\"_blank\">ESTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523842-elasticminus-12-on-wider-loss-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Elastic -12% on wider loss outlook</a></h4><ul><li>Elastic (NYSE:<a href='https://seekingalpha.com/symbol/ESTC' title='Elastic N.V.'>ESTC</a>) <font color=\"red\">plunges 12.2%</font> after the <a href=\"https://seekingalpha.com/news/3523808-elastic-eps-beats-0_09-beats-on-revenue\" target=\"_blank\">Q2 report</a> beats estimates but includes a mixed Q3 outlook with revenue of $106-108M (consensus: $105.8M) and loss per share of $0.36-0.34 (consensus: $0.33 loss).</li><li>The upside FY20 outlook sees $415-417M in revenue and a $1.24-1.17 loss per share.</li><li>SaaS revenue was up 106% Y/Y to $20.6M.</li><li>Calculated billings rose 41% to $125.3M.</li><li>Earnings call starts at 5 PM with a webcast <a href=\"https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fir.elastic.co%2F&amp;esheet=52140057&amp;newsitemid=20191204005888&amp;lan=en-US&amp;anchor=ir.elastic.co&amp;index=1&amp;md5=6984f83af39f2e6a4860c59d08afc5ed\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17718753-elastic-n-v-reports-strong-second-quarter-fiscal-2020-financial-results\" target=\"_blank\">Press release</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523842\" data-linked=\"Elastic -12% on wider loss outlook\" data-tweet=\"$ESTC - Elastic -12% on wider loss outlook https://seekingalpha.com/news/3523842-elasticminus-12-on-wider-loss-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3523842-elasticminus-12-on-wider-loss-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>34&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523840\" data-ts=\"1575495663\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEAC\" target=\"_blank\">SEAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523840-seachange-eps-beats-0_09-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SeaChange EPS beats by $0.09, beats on revenue</a></h4><ul><li>SeaChange (NASDAQ:<a href='https://seekingalpha.com/symbol/SEAC' title='SeaChange International, Inc.'>SEAC</a>): Q3 Non-GAAP EPS of $0.14 <font color=\"green\">beats by $0.09</font>; GAAP EPS of $0.06 <font color=\"green\">beats by $0.04</font>.</li><li>Revenue of $20.54M (+10.4% Y/Y) <font color=\"green\">beats by $1.75M</font>.</li><li>Shares <font color=\"green\">+7.73%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17718797-seachange-international-reports-third-quarter-fiscal-2020-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3523840\" data-linked=\"SeaChange EPS beats by $0.09, beats on revenue\" data-tweet=\"$SEAC - SeaChange EPS beats by $0.09, beats on revenue https://seekingalpha.com/news/3523840-seachange-eps-beats-0_09-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3523840-seachange-eps-beats-0_09-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523838\" data-ts=\"1575495368\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WORK\" target=\"_blank\">WORK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523838-slackminus-5_7-after-beats-inline-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Slack -5.7% after beats, inline outlook</a></h4><ul><li>Slack (NYSE:<a href='https://seekingalpha.com/symbol/WORK' title='Slack Technologies, Inc.'>WORK</a>) <font color=\"red\">-5.7%</font> <a href=\"https://seekingalpha.com/news/3523814-slack-technologies-eps-beats-0_06-beats-on-revenue\" target=\"_blank\">beats Q3 estimates</a> with 60% Y/Y revenue growth. The inline Q4 outlook sees revenue of $172-174M and a loss per share of $0.07-0.06.</li><li>The upside FY20 guidance sees revenue of $621M to $623M with a loss per share of $0.32-0.31.</li><li>In Q3, Slack added 101 paid customers with over $100K in ARR to total 821 (+67% Y/Y) and exceeded 50 customers with over $1M in ARR.</li><li>Calculated billings were up 47% to $186.1M.</li><li>The gross margin was 88.3% compared to 87.5% in last year's quarter. The operating margin was 11% versus 37%.</li><li>Cash used in operations totaled $9.1M with a negative FCF of $19M.</li><li>Board change: Slack <a href=\"https://seekingalpha.com/pr/17718785-slack-appoints-former-flex-ceo-mike-mcnamara-to-board-of-directors\" target=\"_blank\">announces</a> former Flex CEO Michael McNamara as the replacement for Chamath Palihapitiya, who is stepping down.</li><li>Earnings call starts at 5 PM with a webcast <a href=\"http://investor.slackhq.com/\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17718760-slack-announces-record-third-quarter-fiscal-year-2020-results\" target=\"_blank\">Press release</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523838\" data-linked=\"Slack -5.7% after beats, inline outlook\" data-tweet=\"$WORK - Slack -5.7% after beats, inline outlook https://seekingalpha.com/news/3523838-slackminus-5_7-after-beats-inline-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3523838-slackminus-5_7-after-beats-inline-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523834\" data-ts=\"1575495166\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RH\" target=\"_blank\">RH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523834-rh-battles-through-tariff-impact\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RH battles through tariff impact</a></h4><ul> <li>RH (NYSE:<a href='https://seekingalpha.com/symbol/RH' title='RH'>RH</a>) trades lower despite topping estimates on both lines of its Q3 report.</li> <li>The retailer says it sees a clear path to generate over $5B in North America revenue and achieve an operating margin in the high teens to low twenties. Near-term guidance is for Q4 revenue of $703M to $711.5M vs. $709.5M consensus and EPS of $3.50 to $3.62 vs. $3.58 consensus.</li> <li>RH on tariffs: \"We do not expect the current tariffs to impair our ability to achieve stated financial goals and the impact from the increased tariffs is embedded in our guidance for the year. We continue to receive pricing accommodations from vendors and have implemented price increases where necessary with little to no impact to our business.\"</li><li>Shares of RH are <font color=\"red\">down 1.64%</font> AH to $202.25.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3523827-rh-eps-beats-0_54-beats-on-revenue\" target=\"_blank\">RH EPS beats by $0.54, beats on revenue</a> (Dec. 4)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3523834\" data-linked=\"RH battles through tariff impact\" data-tweet=\"$RH - RH battles through tariff impact https://seekingalpha.com/news/3523834-rh-battles-through-tariff-impact?source=tweet\" data-url=\"https://seekingalpha.com/news/3523834-rh-battles-through-tariff-impact\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523828\" data-ts=\"1575494814\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OMER\" target=\"_blank\">OMER</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523828-omeros-readies-equity-offering-shares-down-13-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Omeros readies equity offering; shares down 13% after hours</a></h4><ul><li>Omeros (NASDAQ:<a href='https://seekingalpha.com/symbol/OMER' title='Omeros Corporation'>OMER</a>) <a href=\"https://seekingalpha.com/pr/17718756-omeros-announces-proposed-public-offering-of-common-stock\" target=\"_blank\">launches </a>a public offering of common stock. Price, volume and terms have yet to be announced.</li><li>Shares down <font color=\"red\">13%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523828\" data-linked=\"Omeros readies equity offering; shares down 13% after hours\" data-tweet=\"$OMER - Omeros readies equity offering; shares down 13% after hours https://seekingalpha.com/news/3523828-omeros-readies-equity-offering-shares-down-13-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3523828-omeros-readies-equity-offering-shares-down-13-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>79&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523824\" data-ts=\"1575494529\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AUPH\" target=\"_blank\">AUPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523824-aurinias-voclosporin-successful-in-late-stage-lupus-nephritis-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aurinia&#39;s voclosporin successful in late-stage lupus nephritis study</a></h4><ul><li>A 357-subject <a href=\"https://clinicaltrials.gov/ct2/show/NCT03021499?cond=Lupus+Nephritis&amp;lead=aurinia&amp;phase=2&amp;draw=2&amp;rank=1\" target=\"_blank\">Phase 3 clinical trial</a> evaluating Aurinia Pharmaceuticals' (NASDAQ:<a href='https://seekingalpha.com/symbol/AUPH' title='Aurinia Pharmaceuticals Inc.'>AUPH</a>) lead drug voclosporin, combined with mycophenolate and low-dose corticosteroids, in lupus nephritis patients <a href=\"https://seekingalpha.com/pr/17718725-aurinia-announces-positive-aurora-phase-3-trial-results-demonstrating-voclosporin-superiority\" target=\"_blank\">met the primary</a> and key secondary endpoints.</li><li>Specifically, 40.8% of treated participants achieved renal response at week 52 (the primary endpoint) compared to 22.5% for placebo (p&lt;0.001).</li><li>Statistically significant results were also observed in the proportion of renal responders at week 24 (32.4% vs. 19.7%), partial responders at weeks 24 and 52 and time to achieve a urinary protein-to-creatinine ratio &#40;UCPR&#41; of 0.5 or less.</li><li>No new safety signals were observed.</li><li>Additional data will be submitted for presentation at a future medical conference.</li><li>The company plans to file a U.S. marketing application in H1 2020 under Fast Track status.</li><li>Management will host a conference call tomorrow, December 5, at 8:30 am ET to discuss the results.</li><li>Shares, currently halted, will resume trading at 4:35 pm ET.</li><li><strong>Update</strong>: Shares up <font color=\"green\">115%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523824\" data-linked=\"Aurinia&#39;s voclosporin successful in late-stage lupus nephritis study\" data-tweet=\"$AUPH - Aurinia&#39;s voclosporin successful in late-stage lupus nephritis study https://seekingalpha.com/news/3523824-aurinias-voclosporin-successful-in-late-stage-lupus-nephritis-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3523824-aurinias-voclosporin-successful-in-late-stage-lupus-nephritis-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>109&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523823\" data-ts=\"1575494435\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNPS\" target=\"_blank\">SNPS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523823-synopsysminus-2-on-downside-q1-view\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Synopsys -2% on downside Q1 view</a></h4><ul><li>Synopsys (NASDAQ:<a href='https://seekingalpha.com/symbol/SNPS' title='Synopsys, Inc.'>SNPS</a>) <font color=\"red\">-2.2%</font> <a href=\"https://seekingalpha.com/news/3523798-synopsys-eps-beats-0_02-beats-on-revenue\" target=\"_blank\">reports</a> Q4 beats with revenue up 7% Y/Y. The downside Q1 outlook sees revenue of $805-835M (consensus: $871.3M) and EPS of $0.89-0.94 (consensus: $1.20).</li><li>The FY guidance has inline revenue of $3.6-3.65B and upside EPS of $5.15-5.25 (consensus: $5.08).</li><li>Earnings call starts at 5 PM with a webcast <a href=\"http://www.synopsys.com/\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17718739-synopsys-posts-financial-results-for-fourth-quarter-and-fiscal-year-2019\" target=\"_blank\">Press release</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523823\" data-linked=\"Synopsys -2% on downside Q1 view\" data-tweet=\"$SNPS - Synopsys -2% on downside Q1 view https://seekingalpha.com/news/3523823-synopsysminus-2-on-downside-q1-view?source=tweet\" data-url=\"https://seekingalpha.com/news/3523823-synopsysminus-2-on-downside-q1-view\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:20 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523821\" data-ts=\"1575494354\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMTL\" target=\"_blank\">CMTL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523821-comtechplus-5_7-after-q1-beat-raised-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Comtech +5.7% after Q1 beat, raised guidance</a></h4><ul>   <li>Comtech Telecommunications (NASDAQ:<a href='https://seekingalpha.com/symbol/CMTL' title='Comtech Telecommunications Corp.'>CMTL</a>) is <font color=\"green\">up 5.7%</font> postmarket after topping its own guidance and beating consensus with <a href=\"https://seekingalpha.com/news/3523796-comtech-telecommunications-eps-beats-0_12-beats-on-revenue\" target=\"_blank\">fiscal Q1 earnings</a>.</li>    <li>The year's off to a great start, CEO Fred Kornberg says, and \"Our pipeline of opportunities remains strong and we are tracking a number of strategic orders that bode well for our future.\"</li>    <li>Revenues rose 5.9% to $170.3M.</li>    <li>Bookings were $135.6M, with a companywide book-to-bill ratio of 0.8.</li>    <li>Backlog at quarter's end was $648.3M; the company notes adding that and unfunded value of some multi-year contracts gives revenue visibility of $1B.</li>    <li>That resulted in GAAP operating income of $9.3M and net income of $6.4M. EBITDA was $20.6M (12.1% of consolidated net sales).</li>    <li>It's raising guidance for 2020 net sales to $712M-$732M from a previous $710M-$730M (and vs. consensus for $718.8M), and now sees non-GAAP EPS at $1.42-$1.56 (up from $1.35-$1.50, and vs. consensus for $1.45).</li>    <li><a href=\"https://edge.media-server.com/mmc/p/7pptexwg\" target=\"_blank\">Conference call</a> to come at 4:30 p.m.</li>    <li><a href=\"https://seekingalpha.com/pr/17718694-comtech-telecommunications-corp-announces-results-for-fiscal-2020-first-quarter-and-updates\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3523821\" data-linked=\"Comtech +5.7% after Q1 beat, raised guidance\" data-tweet=\"$CMTL - Comtech +5.7% after Q1 beat, raised guidance https://seekingalpha.com/news/3523821-comtechplus-5_7-after-q1-beat-raised-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3523821-comtechplus-5_7-after-q1-beat-raised-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523818\" data-ts=\"1575494272\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HOME\" target=\"_blank\">HOME</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523818-homeminus-29-after-profit-warning\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">At Home -29% after profit warning</a></h4><ul> <li>At Home Group (NYSE:<a href='https://seekingalpha.com/symbol/HOME' title='At Home Group Inc.'>HOME</a>) slides after issuing disappointing guidance alongside a Q3 earnings beat.</li> <li>Looking ahead, At Home sees FY20 revenue of $1.352B to $1.36B vs. $1.38B consensus and EPS of $0.51 to $0.56 vs. $0.67 to $0.74 prior view and $0.68 consensus.</li><li>\"Our revised outlook for the year primarily reflects weaker performance in our Christmas offering, largely driven by a more promotional holiday environment and the impact of a late Thanksgiving. As a result, we are taking decisive pricing action to address this issue within the current quarter,\" warns the company.</li><li>HOME <font color=\"red\">-28.77%</font> AH to $6.09.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3523802-home-group-eps-beats-0_02-beats-on-revenue\" target=\"_blank\">At Home Group EPS beats by $0.02, beats on revenue</a> (Dec. 4)</li></ul><div class=\"tiny-share-widget\" data-id=\"3523818\" data-linked=\"At Home -29% after profit warning\" data-tweet=\"$HOME - At Home -29% after profit warning https://seekingalpha.com/news/3523818-homeminus-29-after-profit-warning?source=tweet\" data-url=\"https://seekingalpha.com/news/3523818-homeminus-29-after-profit-warning\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523809\" data-ts=\"1575493916\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523809-sportsmans-warehouse-boost-sales-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sportsman&#39;s Warehouse boost sales guidance</a></h4><ul><li>Sportsman's Warehouse (NASDAQ:<a href='https://seekingalpha.com/symbol/SPWH' title='Sportsman&#39;s Warehouse Holdings, Inc.'>SPWH</a>) <font color=\"green\">edges up 0.55%</font> in AH trading after lifting its full-year sales forecast.</li><li>The company expects to generate $891.0M to $901.0M for the year vs. a prior view for $866M to $884M.</li><li>Sportsman's Warehouse anticipates full-year EPS of $0.53 to $0.59 vs. $0.54 consensus.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3523799-sportsmans-warehouse-eps-in-line-beats-on-revenue\" target=\"_blank\">Sportsmans Warehouse EPS in-line, beats on revenue</a> (Dec. 4)</li></ul><div class=\"tiny-share-widget\" data-id=\"3523809\" data-linked=\"Sportsman&#39;s Warehouse boost sales guidance\" data-tweet=\"$SPWH - Sportsman&#39;s Warehouse boost sales guidance https://seekingalpha.com/news/3523809-sportsmans-warehouse-boost-sales-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3523809-sportsmans-warehouse-boost-sales-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523800\" data-ts=\"1575493693\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MLND\" target=\"_blank\">MLND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523800-millendo-therapeutics-readies-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Millendo Therapeutics readies equity offering</a></h4><ul><li>Millendo Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MLND' title='Millendo Therapeutics, Inc.'>MLND</a>) <a href=\"https://seekingalpha.com/pr/17718716-millendo-therapeutics-announces-proposed-public-offering-of-common-stock\" target=\"_blank\">launches </a>a public offering of common stock. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523800\" data-linked=\"Millendo Therapeutics readies equity offering\" data-tweet=\"$MLND - Millendo Therapeutics readies equity offering https://seekingalpha.com/news/3523800-millendo-therapeutics-readies-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3523800-millendo-therapeutics-readies-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523785\" data-ts=\"1575492998\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATO\" target=\"_blank\">ATO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523785-atmos-upped-to-buy-ubs-on-growth-metrics\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Atmos upped to Buy at UBS on growth metrics</a></h4><ul><li>Atmos Energy (<a href='https://seekingalpha.com/symbol/ATO' title='Atmos Energy Corporation'>ATO</a> <font color=\"green\">+1.5%</font>) is higher after UBS <a href=\"https://thefly.com/thestreet/realmoney/index.php/ATOid3001777/ATO-Atmos-Energy-upgraded-to-Buy-from-Neutral-at-UBS\" target=\"_blank\">upgrades shares to Buy</a> from Neutral with a $120 price target, citing \"above average\" growth metrics, earnings stability and \"defensive nature\" of assets.</li><li>ATO recently provided <a href=\"https://seekingalpha.com/pr/17690017-atmos-energy-corporation-reports-earnings-for-fiscal-2019-initiates-fiscal-2020-through\" target=\"_blank\">better than expected</a> guidance for FY 2020 EPS of $4.58-$4.73 and five-year rate base growth, UBS analyst Shneur Gershuni also notes.</li><li>ATO's average <a href=\"https://seekingalpha.com/symbol/ATO/ratings/sell-side-ratings\" target=\"_blank\">Sell Side Rating</a> is Bullish, while its <a href=\"https://seekingalpha.com/symbol/ATO/ratings/author-ratings#filter=all\" target=\"_blank\">Seeking Alpha Authors' Rating</a> and <a href=\"https://seekingalpha.com/symbol/ATO/ratings/quant-ratings\" target=\"_blank\">Quant Rating</a> are both Neutral.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523785\" data-linked=\"Atmos upped to Buy at UBS on growth metrics\" data-tweet=\"$ATO - Atmos upped to Buy at UBS on growth metrics https://seekingalpha.com/news/3523785-atmos-upped-to-buy-ubs-on-growth-metrics?source=tweet\" data-url=\"https://seekingalpha.com/news/3523785-atmos-upped-to-buy-ubs-on-growth-metrics\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523783\" data-ts=\"1575491707\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RESI\" target=\"_blank\">RESI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523783-sale-chatter-boosts-front-yard-residential\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sale chatter boosts Front Yard Residential</a></h4><ul><li>Front Yard Residential (<a href='https://seekingalpha.com/symbol/RESI' title='Front Yard Residential Corporation'>RESI</a> <font color='green'>+6.3%</font>) is perky on M&amp;A chatter. Shares had been halted for volatility, but resumed a few minutes ago.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523783\" data-linked=\"Sale chatter boosts Front Yard Residential\" data-tweet=\"$RESI - Sale chatter boosts Front Yard Residential https://seekingalpha.com/news/3523783-sale-chatter-boosts-front-yard-residential?source=tweet\" data-url=\"https://seekingalpha.com/news/3523783-sale-chatter-boosts-front-yard-residential\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523779\" data-ts=\"1575490294\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QCOM\" target=\"_blank\">QCOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523779-qualcomm-predicts-android-5g-push-in-2020\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Qualcomm predicts Android 5G push in 2020</a></h4><ul><li>Qualcomm (<a href='https://seekingalpha.com/symbol/QCOM' title='QUALCOMM Incorporated'>QCOM</a> <font color='green'>+2.8%</font>) <a href=\"https://www.cnbc.com/2019/12/04/qualcomm-announces-snapdragon-865-and-765-chipset-for-android-phones.html\" target=\"_blank\">expects</a> all high-end Android phones to support 5G next year.</li><li>Yesterday, QCOM <a href=\"https://seekingalpha.com/news/3523446-qualcomm-unveils-new-snapdragon-platforms\" target=\"_blank\">teased its new</a> Snapdragon 865 chip, which the company will sell to makers of top-tier Android phones. The 865 is sold bundled with a separate 5G modem since it lacks integrated 5G.</li><li>Qualcomm says it expects the 865 and the new Snapdragon 765 (for lower-tier phones, does have integrated 5G) to ship to phone makers nearly simultaneously, and the companies could start making announcements in January.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523779\" data-linked=\"Qualcomm predicts Android 5G push in 2020\" data-tweet=\"$QCOM - Qualcomm predicts Android 5G push in 2020 https://seekingalpha.com/news/3523779-qualcomm-predicts-android-5g-push-in-2020?source=tweet\" data-url=\"https://seekingalpha.com/news/3523779-qualcomm-predicts-android-5g-push-in-2020\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523774\" data-ts=\"1575489705\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523774-cootek-and-sequans-communications-among-tech-gainers-jianpu-technology-and-dynatrace-among\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CooTek and Sequans Communications among Tech gainers; Jianpu Technology and Dynatrace among losers</a></h4><ul><li><b>Gainers: </b>CooTek (NYSE:<a href='https://seekingalpha.com/symbol/CTK' title='CooTek &#40;Cayman&#41; Inc.'>CTK</a>) <font color=\"green\">+15%</font>. Sequans Communications (NYSE:<a href='https://seekingalpha.com/symbol/SQNS' title='Sequans Communications S.A.'>SQNS</a>) <font color=\"green\">+10%</font>. Luokung Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/LKCO' title='Luokung Technology Corp.'>LKCO</a>) <font color=\"green\">+10%</font>. B Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/BCOM' title='B Communications Ltd'>BCOM</a>) <font color=\"green\">+9%</font>. RigNet (NASDAQ:<a href='https://seekingalpha.com/symbol/RNET' title='RigNet, Inc.'>RNET</a>) <font color=\"green\">+9%</font>.</li><li><b>Losers: </b>Jianpu Technology (NYSE:<a href='https://seekingalpha.com/symbol/JT' title='Jianpu Technology Inc.'>JT</a>) <font color=\"red\">-16%</font>. Dynatrace (NYSE:<a href='https://seekingalpha.com/symbol/DT' title='Dynatrace, Inc.'>DT</a>) <font color=\"red\">-10%</font>. Pintec Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/PT' title='Pintec Technology Holdings Limited'>PT</a>) <font color=\"red\">-7%</font>. Instructure (NYSE:<a href='https://seekingalpha.com/symbol/INST' title='Instructure, Inc.'>INST</a>) <font color=\"red\">-7%</font>. LogMeIn (NASDAQ:<a href='https://seekingalpha.com/symbol/LOGM' title='LogMeIn, Inc.'>LOGM</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523774\" data-linked=\"CooTek and Sequans Communications among Tech gainers; Jianpu Technology and Dynatrace among losers\" data-tweet=\"$CTK $SQNS $LKCO - CooTek and Sequans Communications among Tech gainers; Jianpu Technology and Dynatrace among losers https://seekingalpha.com/news/3523774-cootek-and-sequans-communications-among-tech-gainers-jianpu-technology-and-dynatrace-among?source=tweet\" data-url=\"https://seekingalpha.com/news/3523774-cootek-and-sequans-communications-among-tech-gainers-jianpu-technology-and-dynatrace-among\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523770\" data-ts=\"1575489015\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DENN\" target=\"_blank\">DENN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523770-dennys-rallies-after-maxim-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Denny&#39;s rallies after Maxim upgrade</a></h4><ul> <li>Maxim Group upgrades Denny's (<a href='https://seekingalpha.com/symbol/DENN' title='Denny&#39;s Corporation'>DENN</a> <font color='green'>+3.2%</font>) to a Buy rating after having the restaurant stock slotted at Hold.</li> <li>The firm points to upside from refranchising savings and sees buybacks as supportive of share price.</li> <li>Maxim lifts its price target on Denny's to $26 from $23 vs. <a href=\"https://seekingalpha.com/symbol/DENN/ratings/sell-side-ratings\" target=\"_blank\">the average sell-side PT</a> of $25.58.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3523770\" data-linked=\"Denny&#39;s rallies after Maxim upgrade\" data-tweet=\"$DENN - Denny&#39;s rallies after Maxim upgrade https://seekingalpha.com/news/3523770-dennys-rallies-after-maxim-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3523770-dennys-rallies-after-maxim-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523769\" data-ts=\"1575488824\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLF\" target=\"_blank\">CLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523769-cleveland-cliffs-deal-for-ak-steel-wins-wall-street-love\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cleveland-Cliffs deal for AK Steel wins some Wall Street love</a></h4><ul><li>Cleveland-Cliffs (<a href='https://seekingalpha.com/symbol/CLF' title='Cleveland-Cliffs Inc.'>CLF</a> <font color='green'>+6.4%</font>) recoups some of yesterday's sharp losses, as investors punished the stock for an <a href=\"https://seekingalpha.com/news/3523429-cleveland-cliffs-plunges-ak-steel-rallies-on-deal-reaction\" target=\"_blank\">\"expensive\" acquisition</a> of AK Steel (<a href='https://seekingalpha.com/symbol/AKS' title='AK Steel Holding Corporation'>AKS</a> <font color='green'>+6.1%</font>), but some Wall Street analysts <a href=\"https://www.barrons.com/articles/cleveland-cliffs-ak-steel-merger-deal-upside-benefits-51575465644\" target=\"_blank\">see merit in the deal</a>.</li><li>CLF CEO Lourenco Goncalves will lead the combined company, and J.P. Morgan's Michael Gambardella thinks \"his leadership and commercial capabilities will be a clear positive\" for AKS.</li><li>Gambardella questions CLF's decision to move from the relative stability of the iron ore business to the more volatile steel industry, but is not concerned about a planned restart of an AKS blast furnace - which would add more steel products to the market - noting the market for U.S.-produced pig iron could grow as companies add more electric arc furnace steelmaking capacity.</li><li>The JPM analyst also upgrades AKS shares to Neutral from Underweight, believing the risk is low that antitrust issues could derail the deal and that another bidder for AKS is not likely to emerge.</li><li>Steel analyst Aldo Mazzaferro tells <em>Barron's</em> that CLF might have hit a \"home run\" on the deal, citing tons of synergies to be had between an iron ore and a steel company.</li><li>Mazzaferro also sees the potential for AKS pig iron to find a home in electric arc furnaces, especially since Pres. Trump just placed tariffs on Brazilian steel. </li></ul><div class=\"tiny-share-widget\" data-id=\"3523769\" data-linked=\"Cleveland-Cliffs deal for AK Steel wins some Wall Street love\" data-tweet=\"$CLF $AKS - Cleveland-Cliffs deal for AK Steel wins some Wall Street love https://seekingalpha.com/news/3523769-cleveland-cliffs-deal-for-ak-steel-wins-wall-street-love?source=tweet\" data-url=\"https://seekingalpha.com/news/3523769-cleveland-cliffs-deal-for-ak-steel-wins-wall-street-love\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>85&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523768\" data-ts=\"1575488756\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALLK\" target=\"_blank\">ALLK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523768-allakos-soars-on-sale-chatter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Allakos soars on sale chatter</a></h4><ul><li>Following a volatility halt, Allakos (NASDAQ:<a href='https://seekingalpha.com/symbol/ALLK' title='Allakos Inc.'>ALLK</a>) is now <font color=\"green\">up 38%</font> on chatter about a possible sale.</li><li><strong>Update</strong>: Bloomberg <a href=\"https://news.bloomberglaw.com/mergers-and-antitrust/u-s-biotech-firm-allakos-said-to-weigh-options-including-sale\" target=\"_blank\">reports </a>that informed sources have confirmed that the company is exploring strategic alternatives and has engaged a financial advisor to assist. Shares are up <font color=\"green\">42%</font> nearing the close on an 8x surge in volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523768\" data-linked=\"Allakos soars on sale chatter\" data-tweet=\"$ALLK - Allakos soars on sale chatter https://seekingalpha.com/news/3523768-allakos-soars-on-sale-chatter?source=tweet\" data-url=\"https://seekingalpha.com/news/3523768-allakos-soars-on-sale-chatter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523766\" data-ts=\"1575488218\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RY\" target=\"_blank\">RY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523766-royal-bank-of-canada-slips-post-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Royal Bank of Canada slips post-earnings</a></h4><ul><li>The major Canadian lenders are in the green today, except for Royal Bank of Canada (<a href='https://seekingalpha.com/symbol/RY' title='Royal Bank of Canada'>RY</a> <font color='red'>-1.8%</font>), which <a href=\"https://seekingalpha.com/news/3523552-royal-bank-of-canada-eps-misses-c-0_06-misses-on-revenue\" target=\"_blank\">reported an earnings miss</a> this morning.</li><li>The company took note of a \"challenging market environment\" in Capital Markets, where earnings were down 4% Y/Y.</li><li>Earnings were down 36% Y/Y in Investor &amp; Treasury Services, with the company noting the short-term interest rate environment, among other factors.</li><li>Personal &amp; Commercial Banking earnings were up 6% Y/Y, mainly thanks to 7% average volume growth.</li><li>Wealth Management earnings were up 13% Y/Y.</li><li>Desjardins bails on its bullish call, downgrading RBC to Hold from Buy.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523766\" data-linked=\"Royal Bank of Canada slips post-earnings\" data-tweet=\"$RY - Royal Bank of Canada slips post-earnings https://seekingalpha.com/news/3523766-royal-bank-of-canada-slips-post-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3523766-royal-bank-of-canada-slips-post-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523765\" data-ts=\"1575488073\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523765-fcc-announces-9b-rural-fund-says-carriers-overstated-coverage\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FCC announces $9B rural fund, says carriers overstated coverage</a></h4><ul>   <li>FCC Chairman Ajit Pai has announced plans to launch a $9B 5G fund for rural America, one intended to kick-start development of advanced mobile wireless across the country.</li>    <li>The planned fund would replace the planned Mobility Fund Phase II, which would have offered federal support for 4G LTE service in unserved areas.</li>    <li>The news comes alongside a <a href=\"https://docs.fcc.gov/public/attachments/DOC-361165A1.pdf\" target=\"_blank\">report on Mobility II</a>, where providers had to submit 4G LTE coverage data in order to help targeting - and the FCC said that data wasn't reliable enough to move forward with Mobility II.</li>    <li>Specifically, after some parties raised complaints, \"staff became concerned that maps submitted by Verizon (<a href=\"http://seekingalpha.com/symbol/VZ\" target=\"_blank\">VZ</a> <font color=\"green\">+0.7%</font>), U.S. Cellular (<a href=\"http://seekingalpha.com/symbol/USM\" target=\"_blank\">USM</a> <font color=\"green\">+2.1%</font>) and T-Mobile (<a href=\"http://seekingalpha.com/symbol/TMUS\" target=\"_blank\">TMUS</a> <font color=\"green\">+0.6%</font>) overstated their coverage and thus were not accurate reflections of actual coverage.\"</li>    <li>Inaccuracies in the data jeopardize the agency's ability to focus federal support where it's needed, the FCC says.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3523765\" data-linked=\"FCC announces $9B rural fund, says carriers overstated coverage\" data-tweet=\"$VZ $USM $TMUS - FCC announces $9B rural fund, says carriers overstated coverage https://seekingalpha.com/news/3523765-fcc-announces-9b-rural-fund-says-carriers-overstated-coverage?source=tweet\" data-url=\"https://seekingalpha.com/news/3523765-fcc-announces-9b-rural-fund-says-carriers-overstated-coverage\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523761\" data-ts=\"1575486121\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523761-pacific-drilling-and-valaris-among-energy-materials-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pacific Drilling and Valaris among Energy/Materials gainers</a></h4><ul><li><b>Gainers: </b>Pacific Drilling (NYSE:<a href='https://seekingalpha.com/symbol/PACD' title='Pacific Drilling S.A.'>PACD</a>) <font color=\"green\">+18%</font>. Valaris (NYSE:<a href='https://seekingalpha.com/symbol/VAL' title='Valaris plc'>VAL</a>) <font color=\"green\">+18%</font>. Whiting Petroleum (NYSE:<a href='https://seekingalpha.com/symbol/WLL' title='Whiting Petroleum Corporation'>WLL</a>) <font color=\"green\">+18%</font>. California Resources (NYSE:<a href='https://seekingalpha.com/symbol/CRC' title='California Resources Corporation'>CRC</a>) <font color=\"green\">+18%</font>. Altus Midstream (NASDAQ:<a href='https://seekingalpha.com/symbol/ALTM' title='Altus Midstream Company'>ALTM</a>) <font color=\"green\">+16%</font>.</li><li><b>Losers: </b>NA</li></ul><div class=\"tiny-share-widget\" data-id=\"3523761\" data-linked=\"Pacific Drilling and Valaris among Energy/Materials gainers\" data-tweet=\"$PACD $VAL $WLL - Pacific Drilling and Valaris among Energy/Materials gainers https://seekingalpha.com/news/3523761-pacific-drilling-and-valaris-among-energy-materials-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3523761-pacific-drilling-and-valaris-among-energy-materials-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523882\" data-ts=\"1575485755\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UNP\" target=\"_blank\">UNP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523882-union-pacific-warns-on-q4-volumes-sharesplus-2-anyway\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Union Pacific warns on Q4 volumes but shares +2% anyway</a></h4><ul><li>Union Pacific (<a href='https://seekingalpha.com/symbol/UNP' title='Union Pacific Corporation'>UNP</a> <font color='green'>+2.1%</font>) says it expects Q4 volumes to <a href=\"https://www.sec.gov/ix?doc=/Archives/edgar/data/100885/000010088519000284/unp-20191204x8k.htm\" target=\"_blank\">decline by at least 10%</a> from the prior-year quarter and revenue to drop by a \"similar\" but slightly lower percentage than volumes, but the stock is poised to snap a five-session losing streak.</li><li>CFO Robert Knight also told the Credit Suisse Industrials Conference that the company expects to report an operating ratio result below 61% for the full year.</li><li>In October, Knight said he expected Q4 volume would decline \"at a similar level\" to the 8% drop in Q3.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523882\" data-linked=\"Union Pacific warns on Q4 volumes but shares +2% anyway\" data-tweet=\"$UNP - Union Pacific warns on Q4 volumes but shares +2% anyway https://seekingalpha.com/news/3523882-union-pacific-warns-on-q4-volumes-sharesplus-2-anyway?source=tweet\" data-url=\"https://seekingalpha.com/news/3523882-union-pacific-warns-on-q4-volumes-sharesplus-2-anyway\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523750\" data-ts=\"1575484069\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523750-wileyplus-1_8-q2-profits-top-consensus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wiley +1.8% as Q2 profits top consensus</a></h4><ul>   <li>John Wiley &amp; Sons is higher (<a href='https://seekingalpha.com/symbol/JW.A' title='John Wiley & Sons, Inc.'>JW.A</a> <font color=\"green\">+1.8%</font>, <a href='https://seekingalpha.com/symbol/JW.B' title='John Wiley & Sons, Inc.'>JW.B</a> <font color=\"green\">+1.8%</font>) after topping profit expectations with its <a href=\"https://seekingalpha.com/news/3523608-john-wiley-sons-eps-beats-0_20-misses-on-revenue\" target=\"_blank\">fiscal Q2 report</a>.</li>    <li>Revenues fell short, rising just 3.9% to $466.2M. At constant currency, they rose 5%.</li>    <li>Operating income rose 10% thanks both to revenue growth and efficiency gains along with lower expenses and restructuring charges.</li>    <li>EPS rose 4% on a GAAP basis (down 1% on an adjusted basis), and adjusted EBITDA was up 3% (to $110M).</li>    <li>Revenue by segment: Research Publishing &amp; Platforms, $234.7M (up 2%); Academic &amp; Professional Learning, $177.7M (down 6%); Education Services, 453.8M (up 80%).</li>    <li>Contribution to profit by segment: Research Publishing &amp; Platforms, $63.3M (up 7%); Academic &amp; Professional Learning, $35.1M (down 26%); Education Services, $2.6M.</li>    <li>For the full year, it's reaffirming its outlook for revenue of $1.855B-$1.885B, EBITDA of $357M-$372M, EPS of $2.35-$2.45 and free cash flow of $210M-$230M.</li>    <li><a href=\"https://seekingalpha.com/pr/17717801-wiley-reports-second-quarter-fiscal-2020-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3523750\" data-linked=\"Wiley +1.8% as Q2 profits top consensus\" data-tweet=\"$JW.A $JW.B - Wiley +1.8% as Q2 profits top consensus https://seekingalpha.com/news/3523750-wileyplus-1_8-q2-profits-top-consensus?source=tweet\" data-url=\"https://seekingalpha.com/news/3523750-wileyplus-1_8-q2-profits-top-consensus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:27 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523749\" data-ts=\"1575483395\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/REAL\" target=\"_blank\">REAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523749-credit-suisse-confident-on-realreal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Credit Suisse confident on RealReal</a></h4><ul><li>Credit Suisse says it has reinforced confidence in Outperform-rated The RealReal (<a href='https://seekingalpha.com/symbol/REAL' title='The RealReal, Inc.'>REAL</a> <font color='green'>+7%</font>) after meeting management at a conference.</li><li>\"Despite increased media attention lately around authentication, we think REAL\u2019s business fundamentals are intact. We think the combination of best-in-class revenue growth, along with solid progress towards long-term margin targets (as REAL pushes further into automation) should put upward pressure on Street estimates through the year\u2014which we think will put consistent pressure on the bear case,\" notes the firm</li><li>Credit Suisse's price target of $30 is 5X the 2021 sales estimate and above the <a href=\"https://seekingalpha.com/symbol/REAL/ratings/sell-side-ratings\" target=\"_blank\">average sell-side PT</a> of $29.57.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523749\" data-linked=\"Credit Suisse confident on RealReal\" data-tweet=\"$REAL - Credit Suisse confident on RealReal https://seekingalpha.com/news/3523749-credit-suisse-confident-on-realreal?source=tweet\" data-url=\"https://seekingalpha.com/news/3523749-credit-suisse-confident-on-realreal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523880\" data-ts=\"1575483238\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WWD\" target=\"_blank\">WWD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523880-woodward-upgraded-to-buy-jefferies-on-aerospace-potential\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Woodward upgraded to Buy at Jefferies on aerospace potential</a></h4><ul><li>Woodward (<a href='https://seekingalpha.com/symbol/WWD' title='Woodward, Inc.'>WWD</a> <font color='green'>+3.4%</font>) touches a 52-week high after Jefferies <a href=\"https://thefly.com/thestreet/realmoney/index.php/WWDid3001914/WWD-Woodward-upgraded-to-Buy-on-potential-for-Aerospace-upside-at-Jefferies\" target=\"_blank\">upgrades shares to Buy</a> from Hold with a $135 price target, believing management is conservative with its operating margin targets for the aerospace business, which accounts for 75% of earnings and could surprise to the upside.</li><li>Jefferies analyst Sheila Kahyaoglu also notes the scarcity value of WWD  given that few commercial aerospace assets are available for  interested buyers.</li><li>She raises her FY 2020 EPS estimate for WWD to $5.60, which is at the high end of company guidance of $5.30-$5.60  and above Wall Street consensus at $5.47.</li><li>WWD's average <a href=\"https://seekingalpha.com/symbol/WWD/ratings/sell-side-ratings\" target=\"_blank\">Sell Side Rating</a> is Bullish, and its <a href=\"https://seekingalpha.com/symbol/WWD/ratings/quant-ratings\" target=\"_blank\">Quant Rating</a> is Neutral.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523880\" data-linked=\"Woodward upgraded to Buy at Jefferies on aerospace potential\" data-tweet=\"$WWD - Woodward upgraded to Buy at Jefferies on aerospace potential https://seekingalpha.com/news/3523880-woodward-upgraded-to-buy-jefferies-on-aerospace-potential?source=tweet\" data-url=\"https://seekingalpha.com/news/3523880-woodward-upgraded-to-buy-jefferies-on-aerospace-potential\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523743\" data-ts=\"1575483037\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ECOR\" target=\"_blank\">ECOR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523743-electrocore-up-20-after-corporate-presentation-sapphire-prospects\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ElectroCore up 20% after corporate presentation, Sapphire prospects</a></h4><ul><li>Thinly traded nano cap electroCore (<a href='https://seekingalpha.com/symbol/ECOR' title='electroCore, Inc.'>ECOR</a> <font color=\"green\">+19.6%</font>) is up on modestly higher volume, 284K shares, following this morning's presentation at the <a href=\"https://seekingalpha.com/pr/17711936-electrocore-to-present-two-december-investor-conferences\" target=\"_blank\">Evercore ISI HealthCONx Conference</a> in Boston. Investors appear bullish on the company's outlook.</li><li>The FDA <a href=\"https://www.accessdata.fda.gov/cdrh_docs/pdf18/K182369.pdf\" target=\"_blank\">cleared </a>its gammaCore Sapphire device, a non-invasive vagus nerve stimulator, last week for the prevention and treatment of cluster headache and acute migraine.</li><li>Yesterday, the UK's NICE, the advisor to the National Health Service on cost and care quality, <a href=\"https://seekingalpha.com/pr/17715711-nice-recommends-use-of-gammacore-for-treatment-of-cluster-headache-in-nhs\" target=\"_blank\">recommended</a> routine access for cluster headache.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523743\" data-linked=\"ElectroCore up 20% after corporate presentation, Sapphire prospects\" data-tweet=\"$ECOR - ElectroCore up 20% after corporate presentation, Sapphire prospects https://seekingalpha.com/news/3523743-electrocore-up-20-after-corporate-presentation-sapphire-prospects?source=tweet\" data-url=\"https://seekingalpha.com/news/3523743-electrocore-up-20-after-corporate-presentation-sapphire-prospects\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523746\" data-ts=\"1575482654\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523746-capstone-turbine-leads-industrial-gainers-newater-technology-only-loser\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Capstone Turbine leads industrial gainers; Newater Technology only loser</a></h4><ul><li><b>Gainers: </b>Capstone Turbine (NASDAQ:<a href='https://seekingalpha.com/symbol/CPST' title='Capstone Turbine Corporation'>CPST</a>) <font color=\"green\">+19%</font>. Coda Octopus (NASDAQ:<a href='https://seekingalpha.com/symbol/CODA' title='Coda Octopus Group, Inc.'>CODA</a>) <font color=\"green\">+10%</font>. Ideal Power (NASDAQ:<a href='https://seekingalpha.com/symbol/IPWR' title='Ideal Power Inc.'>IPWR</a>) <font color=\"green\">+9%</font>. Hebron Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/HEBT' title='Hebron Technology Co., Ltd.'>HEBT</a>) <font color=\"green\">+9%</font>. The Dixie Group (NASDAQ:<a href='https://seekingalpha.com/symbol/DXYN' title='The Dixie Group, Inc.'>DXYN</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>Newater Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/NEWA' title='Newater Technology, Inc.'>NEWA</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523746\" data-linked=\"Capstone Turbine leads industrial gainers; Newater Technology only loser\" data-tweet=\"$CPST $CODA $IPWR - Capstone Turbine leads industrial gainers; Newater Technology only loser https://seekingalpha.com/news/3523746-capstone-turbine-leads-industrial-gainers-newater-technology-only-loser?source=tweet\" data-url=\"https://seekingalpha.com/news/3523746-capstone-turbine-leads-industrial-gainers-newater-technology-only-loser\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523745\" data-ts=\"1575482486\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523745-icici-bank-among-financial-gainers-realogy-and-cannae-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ICICI Bank among financial gainers; Realogy and Cannae  among losers</a></h4><ul><li><b>Gainers: </b>Banco Macro (NYSE:<a href='https://seekingalpha.com/symbol/BMA' title='Banco Macro S.A.'>BMA</a>) <font color=\"green\">+7%</font>. Vista Oil &amp; Gas (NYSE:<a href='https://seekingalpha.com/symbol/VIST' title='Vista Oil & Gas, S.A.B. de C.V.'>VIST</a>) <font color=\"green\">+6%</font>. Banco de Chile (NYSE:<a href='https://seekingalpha.com/symbol/BCH' title='Banco de Chile'>BCH</a>) <font color=\"green\">+6%</font>. ICICI Bank (NYSE:<a href='https://seekingalpha.com/symbol/IBN' title='ICICI Bank Limited'>IBN</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>China Rapid Finance (NYSE:<a href='https://seekingalpha.com/symbol/XRF' title='China Rapid Finance Limited'>XRF</a>) <font color=\"red\">-14%</font>. CPI Card (NASDAQ:<a href='https://seekingalpha.com/symbol/PMTS' title='CPI Card Group Inc.'>PMTS</a>) <font color=\"red\">-8%</font>. Weidai (NYSE:<a href='https://seekingalpha.com/symbol/WEI' title='Weidai Ltd.'>WEI</a>) <font color=\"red\">-8%</font>. Realogy (NYSE:<a href='https://seekingalpha.com/symbol/RLGY' title='Realogy Holdings Corp.'>RLGY</a>) <font color=\"red\">-6%</font>. Cannae (NYSE:<a href='https://seekingalpha.com/symbol/CNNE' title='Cannae Holdings, Inc.'>CNNE</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523745\" data-linked=\"ICICI Bank among financial gainers; Realogy and Cannae  among losers\" data-tweet=\"$BMA $VIST $BCH - ICICI Bank among financial gainers; Realogy and Cannae among losers https://seekingalpha.com/news/3523745-icici-bank-among-financial-gainers-realogy-and-cannae-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3523745-icici-bank-among-financial-gainers-realogy-and-cannae-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523737\" data-ts=\"1575482038\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VAL\" target=\"_blank\">VAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523737-significant-board-changes-needed-valaris-activist-shareholder-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">&#39;Significant board changes&#39; needed at Valaris, activist shareholder says</a></h4><ul><li>Valaris (<a href='https://seekingalpha.com/symbol/VAL' title='Valaris plc'>VAL</a> <font color=\"green\">+15.5%</font>) vaults higher after Luminus Management issued a <a href=\"https://seekingalpha.com/pr/17718046-luminus-management-to-call-meeting-of-valaris-shareholders-to-upgrade-valaris-board\" target=\"_blank\">letter to shareholders</a> saying shares could be worth at least 4x current levels if the company was \"appropriately governed\" and should shareholders gain \"renewed confidence in [the company's] future direction.\"</li><li>Luminus believes VAL has underperformed \"on both an absolute and relative basis over almost every relevant time period\" despite owning \"a superior asset base, a robust liquidity profile and access to secured debt markets.\"</li><li>The activist shareholder, which <a href=\"https://seekingalpha.com/news/3521830-valaris-discloses-18_7-active-stake-luminus\" target=\"_blank\">owns an 18.7% stake</a> in VAL, says it is \"unfathomable that a company with such a high-quality asset base and abundant liquidity would trade as if a restructuring or default were imminent.\"</li><li>Luminus is calling for a shareholders meeting to seek \"significant board changes\" to reverse the company's \"chronic underperformance.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3523737\" data-linked=\"&#39;Significant board changes&#39; needed at Valaris, activist shareholder says\" data-tweet=\"$VAL - &#39;Significant board changes&#39; needed at Valaris, activist shareholder says https://seekingalpha.com/news/3523737-significant-board-changes-needed-valaris-activist-shareholder-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3523737-significant-board-changes-needed-valaris-activist-shareholder-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>33&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523739\" data-ts=\"1575481600\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVTA\" target=\"_blank\">NVTA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523739-invitae-down-5-on-bearish-hedgeye-call\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Invitae down 5% on bearish Hedgeye call</a></h4><ul><li>Genetic testing services provider Invitae (<a href='https://seekingalpha.com/symbol/NVTA' title='Invitae Corporation'>NVTA</a> <font color=\"red\">-4.8%</font>) slips on below-average volume in apparent response to a new (but not yet posted) report from independent research shop <a href=\"https://app.hedgeye.com/\" target=\"_blank\">Hedgeye </a>that sees a 30 - 50% downside in shares.</li><li>The stock is currently exchanging hands at $18.14, down <font color=\"red\">37% </font>from the all-time high of $28.75 on August 7.</li><li>Q3 revenue was up 51% to $56.5M, $1.7M above consensus.</li><li>Q4 views expect a loss/share of ($0.67) on revenue of $69.2M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523739\" data-linked=\"Invitae down 5% on bearish Hedgeye call\" data-tweet=\"$NVTA - Invitae down 5% on bearish Hedgeye call https://seekingalpha.com/news/3523739-invitae-down-5-on-bearish-hedgeye-call?source=tweet\" data-url=\"https://seekingalpha.com/news/3523739-invitae-down-5-on-bearish-hedgeye-call\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523740\" data-ts=\"1575481531\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHOP\" target=\"_blank\">SHOP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523740-shopifyplus-5_9-cramer-raises-m-chatter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shopify +5.9% as Cramer raises M&amp;A chatter</a></h4><ul>   <li>Shopify (NYSE:<a href='https://seekingalpha.com/symbol/SHOP' title='Shopify Inc.'>SHOP</a>) has legged up to a <font color=\"green\">5.9% gain</font> after CNBC's Jim Cramer mentions it in M&amp;A speculation.</li>    <li>At least two companies Cramer met with want to buy Shopify, he said, and both companies are over $70B in market capitalization.</li>    <li>Shopify's been resistant to a sale so far, however.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3523740\" data-linked=\"Shopify +5.9% as Cramer raises M&amp;A chatter\" data-tweet=\"$SHOP - Shopify +5.9% as Cramer raises M&amp;A chatter https://seekingalpha.com/news/3523740-shopifyplus-5_9-cramer-raises-m-chatter?source=tweet\" data-url=\"https://seekingalpha.com/news/3523740-shopifyplus-5_9-cramer-raises-m-chatter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>193&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523738\" data-ts=\"1575481310\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523738-cpst-crc-rvnc-and-ormp-among-notable-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CPST, CRC, RVNC and ORMP among notable midday movers</a></h4><ul><li><strong>Gainers: </strong>Protagonist Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PTGX' title='Protagonist Therapeutics, Inc.'>PTGX</a>) <font color=\"green\">+63%</font>.</li><li>Arbutus Biopharma (NASDAQ:<a href='https://seekingalpha.com/symbol/ABUS' title='Arbutus Biopharma Corporation'>ABUS</a>) <font color=\"green\">+22%</font>.</li><li>Kodiak Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/KOD' title='Kodiak Sciences Inc.'>KOD</a>) <font color=\"green\">+22%</font>.</li><li>Galmed Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/GLMD' title='Galmed Pharmaceuticals Ltd.'>GLMD</a>) <font color=\"green\">+22%</font>.</li><li>Jounce Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/JNCE' title='Jounce Therapeutics, Inc.'>JNCE</a>) <font color=\"green\">+19%</font>.</li><li>Capstone Turbine (NASDAQ:<a href='https://seekingalpha.com/symbol/CPST' title='Capstone Turbine Corporation'>CPST</a>) <font color=\"green\">+17%</font>.</li><li>California Resources (NYSE:<a href='https://seekingalpha.com/symbol/CRC' title='California Resources Corporation'>CRC</a>) <font color=\"green\">+17%</font>.</li><li>Can-Fite BioPharma (NYSEMKT:<a href='https://seekingalpha.com/symbol/CANF' title='Can-Fite BioPharma Ltd.'>CANF</a>) <font color=\"green\">+17%</font>.</li><li>Pacific Drilling (NYSE:<a href='https://seekingalpha.com/symbol/PACD' title='Pacific Drilling S.A.'>PACD</a>) <font color=\"green\">+17%</font>.</li><li>La Jolla Pharmaceutical (NASDAQ:<a href='https://seekingalpha.com/symbol/LJPC' title='La Jolla Pharmaceutical Company'>LJPC</a>) <font color=\"green\">+17%</font>.</li><li><strong>Losers: </strong>Barnes &amp; Noble Education (NYSE:<a href='https://seekingalpha.com/symbol/BNED' title='Barnes & Noble Education, Inc.'>BNED</a>) <font color=\"red\">-20%</font>.</li><li>Revance Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/RVNC' title='Revance Therapeutics, Inc.'>RVNC</a>) <font color=\"red\">-17%</font>.</li><li>Outlook Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/OTLK' title='Outlook Therapeutics, Inc.'>OTLK</a>) <font color=\"red\">-16%</font>.</li><li>Jianpu Technology (NYSE:<a href='https://seekingalpha.com/symbol/JT' title='Jianpu Technology Inc.'>JT</a>) <font color=\"red\">-15%</font>.</li><li>Oramed Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ORMP' title='Oramed Pharmaceuticals Inc.'>ORMP</a>) <font color=\"red\">-13%</font>.</li><li>China Rapid Finance (NYSE:<a href='https://seekingalpha.com/symbol/XRF' title='China Rapid Finance Limited'>XRF</a>) <font color=\"red\">-12%</font>.</li><li>NuCana (NASDAQ:<a href='https://seekingalpha.com/symbol/NCNA' title='NuCana plc'>NCNA</a>) <font color=\"red\">-11%</font>.</li><li>Ardelyx (NASDAQ:<a href='https://seekingalpha.com/symbol/ARDX' title='Ardelyx, Inc.'>ARDX</a>) <font color=\"red\">-10%</font>.</li><li>Dynatrace (NYSE:<a href='https://seekingalpha.com/symbol/DT' title='Dynatrace, Inc.'>DT</a>) <font color=\"red\">-9%</font>.</li><li>Iterum Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ITRM' title='Iterum Therapeutics plc'>ITRM</a>) <font color=\"red\">-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523738\" data-linked=\"CPST, CRC, RVNC and ORMP among notable midday movers\" data-tweet=\"$PTGX $ABUS $KOD - CPST, CRC, RVNC and ORMP among notable midday movers https://seekingalpha.com/news/3523738-cpst-crc-rvnc-and-ormp-among-notable-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3523738-cpst-crc-rvnc-and-ormp-among-notable-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523735\" data-ts=\"1575480595\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZEAL\" target=\"_blank\">ZEAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523735-zealand-pharma-up-6-on-dasiglucagon-developments\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zealand Pharma up 6% on dasiglucagon developments</a></h4><ul><li>Ultra-thinly traded Zealand Pharma (<a href='https://seekingalpha.com/symbol/ZEAL' title='Zealand Pharma A/S'>ZEAL</a> <font color=\"green\">+6.3%</font>) is up, albeit on turnover of only 3,200 shares, in apparent reaction to dasiglucagon-related news, in late-stage development for severe hypoglycemia (low blood sugar).</li><li>Earlier today the company <a href=\"https://seekingalpha.com/pr/17718029-zealand-pharma-initiates-second-phase-3-trial-dasiglucagon-for-treatment-of-congenital\" target=\"_blank\">announced </a>a second Phase 3 study in children with congenital hyperinsulinism &#40;CHI&#41;, an inherited disorder that causes hypoglycemia due to excess amounts of insulin secreted by the pancreas.</li><li>It also announced that the FDA has granted Rare Pediatric Disease designation to the glucagon analog for CHI which provides for the issuance of a rare pediatric disease priority review voucher following the agency's nod. The voucher can be used for accelerated approval of a future application or it can be sold to a third party.</li><li>Shares rose <font color=\"green\">8%</font> in Copenhagen today closing at DKK220.0.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523735\" data-linked=\"Zealand Pharma up 6% on dasiglucagon developments\" data-tweet=\"$ZEAL - Zealand Pharma up 6% on dasiglucagon developments https://seekingalpha.com/news/3523735-zealand-pharma-up-6-on-dasiglucagon-developments?source=tweet\" data-url=\"https://seekingalpha.com/news/3523735-zealand-pharma-up-6-on-dasiglucagon-developments\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523733\" data-ts=\"1575480091\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523733-pelotonminus-4-company-plays-defense\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Peloton -4% as company plays defense</a></h4><ul> <li>Peloton (NASDAQ:<a href='https://seekingalpha.com/symbol/PTON' title='Peloton Interactive, Inc.'>PTON</a>) has swung lower after the company responded to criticism over its holiday ad that featured a wife receiving a Peloton bike from her husband.</li> <li>\"Our holiday spot was created to celebrate that fitness and wellness journey. While we're disappointed in how some have misinterpreted this commercial, we are encouraged by \u2014 and grateful for \u2014 the outpouring of support we\u2019ve received from those who understand what we were trying to communicate,\" reads part of the company's statement.</li> <li>While analysts largely supported Peloton yesterday and predicted little long-term impact from the social media flareup, Peloton's defense today has put the issue back on the front burner.</li> <li>Peloton is <font color=\"red\">down 3.82%</font> on volume of over 4M shares.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3523314-peloton-ad-goes-viral\" target=\"_blank\">Peloton ad goes viral</a> (Dec. 3)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3523442-raymond-james-defends-peloton\" target=\"_blank\">Raymond James defends Peloton</a> (Dec. 3)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3523733\" data-linked=\"Peloton -4% as company plays defense\" data-tweet=\"$PTON - Peloton -4% as company plays defense https://seekingalpha.com/news/3523733-pelotonminus-4-company-plays-defense?source=tweet\" data-url=\"https://seekingalpha.com/news/3523733-pelotonminus-4-company-plays-defense\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>45&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523731\" data-ts=\"1575480030\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PCG\" target=\"_blank\">PCG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523731-pg-and-e-nears-13_5b-deal-wildfire-victims-bloomberg\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PG&amp;E nears $13.5B deal with wildfire victims - Bloomberg</a></h4><ul><li>PG&amp;E (<a href='https://seekingalpha.com/symbol/PCG' title='PG&E Corporation'>PCG</a> <font color=\"green\">+11.2%</font>) pops higher after the company is said to be <a href=\"https://finance.yahoo.com/news/pg-e-near-13-5-171237808.html\" target=\"_blank\">close to finalizing terms</a> for a $13.5B settlement with wildfire victims, a key step toward resolving its bankruptcy case, Bloomberg reports.</li><li>PG&amp;E would pay half in cash and the other half in stock in the newly reorganized utility, according to the report.</li><li>PG&amp;E last month reportedly proposed $13.5B in compensation to the victims, but the two sides were said to be at odds over how to structure the payout and how much should come in the form of cash and stock.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523731\" data-linked=\"PG&amp;E nears $13.5B deal with wildfire victims - Bloomberg\" data-tweet=\"$PCG - PG&amp;E nears $13.5B deal with wildfire victims - Bloomberg https://seekingalpha.com/news/3523731-pg-and-e-nears-13_5b-deal-wildfire-victims-bloomberg?source=tweet\" data-url=\"https://seekingalpha.com/news/3523731-pg-and-e-nears-13_5b-deal-wildfire-victims-bloomberg\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>46&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523729\" data-ts=\"1575479973\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMCSA\" target=\"_blank\">CMCSA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523729-comcast-sets-investor-meeting-on-streaming-strategy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Comcast sets investor meeting on streaming strategy</a></h4><ul>   <li>Comcast (<a href=\"http://seekingalpha.com/symbol/CMCSA\" target=\"_blank\">CMCSA</a> <font color=\"green\">+2.4%</font>) has set an <a href=\"https://seekingalpha.com/pr/17718223-comcast-to-host-investor-meeting-to-discuss-nbcuniversal-s-peacock-streaming-service\" target=\"_blank\">investor meeting</a> to go over its strategy for Peacock, its upcoming entry in the streaming-video wars.</li>    <li>The meeting is set for 4 p.m. ET on Thursday, Jan. 16.</li>    <li>It will be webcast live via the company's investor relations site.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3523729\" data-linked=\"Comcast sets investor meeting on streaming strategy\" data-tweet=\"$CMCSA - Comcast sets investor meeting on streaming strategy https://seekingalpha.com/news/3523729-comcast-sets-investor-meeting-on-streaming-strategy?source=tweet\" data-url=\"https://seekingalpha.com/news/3523729-comcast-sets-investor-meeting-on-streaming-strategy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523714\" data-ts=\"1575479408\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TNDM\" target=\"_blank\">TNDM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523714-tandem-down-7-on-expected-headwinds-control-iq-approval\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tandem down 7% on expected headwinds before Control-IQ approval</a></h4><ul><li>Tandem Diabetes Care (<a href='https://seekingalpha.com/symbol/TNDM' title='Tandem Diabetes Care, Inc.'>TNDM</a> <font color=\"red\">-6.9%</font>) slumps on average volume on the heels of its <a href=\"http://investor.tandemdiabetes.com/events-and-presentations\" target=\"_blank\">presentation</a> at the Piper Jaffray Healthcare Conference today.</li><li>Investors appear to be reacting to a temporary slowdown in business as U.S. customers wait for the FDA nod on Control-IQ, expected in the near future. The company said that it saw a slowdown in late Q3 that will extend through almost all of Q4. About 105K U.S. patients currently use their pump and 80% of those can be updated to Control-IQ (company plans to offer the update at no charge).</li><li>There is also looming competition from a new Medtronic device, expected about mid-2020.</li><li>U.S. market for insulin pumps currently 30% penetrated compared to 24% ~15 years ago (analyst comment) but the company envisions 50% penetration in the next 3-5 years driven primarily by much improved ease of use.</li><li>The company's income is ~$4K per pump in the U.S. versus ~$2K in Europe (due to broader range of distributor responsibilities there).</li><li>Agreement with Abbott should be finalized shortly. May be about a year before commercialization begins on Libre 2.0 device. Meaningful revenue expected no earlier than 2021.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523714\" data-linked=\"Tandem down 7% on expected headwinds before Control-IQ approval\" data-tweet=\"$TNDM - Tandem down 7% on expected headwinds before Control-IQ approval https://seekingalpha.com/news/3523714-tandem-down-7-on-expected-headwinds-control-iq-approval?source=tweet\" data-url=\"https://seekingalpha.com/news/3523714-tandem-down-7-on-expected-headwinds-control-iq-approval\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523708\" data-ts=\"1575478723\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523708-tata-motors-among-consumer-gainers-g-iii-apparel-only-loser\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tata Motors among consumer gainers; G-III Apparel only loser</a></h4><ul><li><b>Gainers: </b>Unique Fabricating (NYSEMKT:<a href='https://seekingalpha.com/symbol/UFAB' title='Unique Fabricating, Inc.'>UFAB</a>) <font color=\"green\">+17%</font>. Tata Motors (NYSE:<a href='https://seekingalpha.com/symbol/TTM' title='Tata Motors Limited'>TTM</a>) <font color=\"green\">+8%</font>. Natural Health Trends (NASDAQ:<a href='https://seekingalpha.com/symbol/NHTC' title='Natural Health Trends Corp.'>NHTC</a>) <font color=\"green\">+7%</font>. Resolute Forest Products (NYSE:<a href='https://seekingalpha.com/symbol/RFP' title='Resolute Forest Products Inc.'>RFP</a>) <font color=\"green\">+7%</font>. China Automotive Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/CAAS' title='China Automotive Systems, Inc.'>CAAS</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>G-III Apparel (NASDAQ:<a href='https://seekingalpha.com/symbol/GIII' title='G-III Apparel Group, Ltd.'>GIII</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523708\" data-linked=\"Tata Motors among consumer gainers; G-III Apparel only loser\" data-tweet=\"$UFAB $TTM $NHTC - Tata Motors among consumer gainers; G-III Apparel only loser https://seekingalpha.com/news/3523708-tata-motors-among-consumer-gainers-g-iii-apparel-only-loser?source=tweet\" data-url=\"https://seekingalpha.com/news/3523708-tata-motors-among-consumer-gainers-g-iii-apparel-only-loser\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523694\" data-ts=\"1575477175\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IDCC\" target=\"_blank\">IDCC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523694-interdigital-sues-huawei-over-patents-for-3g-4g-5g\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">InterDigital sues Huawei over patents for 3G, 4G, 5G</a></h4><ul>   <li>InterDigital (<a href=\"http://seekingalpha.com/symbol/IDCC\" target=\"_blank\">IDCC</a> <font color=\"green\">+2.1%</font>) has <a href=\"https://seekingalpha.com/pr/17717561-interdigital-files-patent-infringement-action-against-huawei-in-uk\" target=\"_blank\">sued Huawei</a> in the United Kingdom over standards-essential patents for 3G, 4G and 5G technology.</li>    <li>It's acting after 18 months of negotiation and the expiration of a previous SEP license Huawei had with InterDigital, one reached after lengthy arbitration.</li>    <li>InterDigital says it's made clear to Huawei that it's willing to have an impartial panel of arbitrators determine fair, reasonable and non-discriminatory terms and conditions for a new license.</li>    <li>In its suit, it's seeking a declaration that its terms are consistent with its FRAND commitments.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3523694\" data-linked=\"InterDigital sues Huawei over patents for 3G, 4G, 5G\" data-tweet=\"$IDCC - InterDigital sues Huawei over patents for 3G, 4G, 5G https://seekingalpha.com/news/3523694-interdigital-sues-huawei-over-patents-for-3g-4g-5g?source=tweet\" data-url=\"https://seekingalpha.com/news/3523694-interdigital-sues-huawei-over-patents-for-3g-4g-5g\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523691\" data-ts=\"1575476372\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHK\" target=\"_blank\">CHK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523691-chesapeake-energy-gets-1_5b-lifeline-shares-spike-15\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chesapeake Energy gets $1.5B lifeline; shares spike 15%</a></h4><ul><li>Chesapeake Energy (<a href='https://seekingalpha.com/symbol/CHK' title='Chesapeake Energy Corporation'>CHK</a> <font color=\"green\">+14.9%</font>) surges on news it <a href=\"https://seekingalpha.com/pr/17717914-chesapeake-energy-corporation-announces-arrangement-of-1_5-billion-term-loan-facility\" target=\"_blank\">secured a $1.5B term loan facility</a> - a lifeline for the company that issued a going concern warning <a href=\"https://seekingalpha.com/news/3514479-chesapeake-issues-going-concern-warning-alongside-q3-loss\" target=\"_blank\">a month ago</a>.</li><li>CHK says it plans to use the loan proceeds to finance a <a href=\"https://seekingalpha.com/pr/17717909-chesapeake-energy-corporation-announces-cash-tender-offer-and-consent-solicitation-for-6_875\" target=\"_blank\">tender offer</a> and consent solicitation for notes issued by Brazos Valley Longhorn and to fund the retirement of Brazos Valley's existing secured revolving credit facility.</li><li>CHK says the transactions should improve its financial  flexibility, as they will allow Brazos Valley and its subsidiaries to  support CHK's current and future debt.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523691\" data-linked=\"Chesapeake Energy gets $1.5B lifeline; shares spike 15%\" data-tweet=\"$CHK - Chesapeake Energy gets $1.5B lifeline; shares spike 15% https://seekingalpha.com/news/3523691-chesapeake-energy-gets-1_5b-lifeline-shares-spike-15?source=tweet\" data-url=\"https://seekingalpha.com/news/3523691-chesapeake-energy-gets-1_5b-lifeline-shares-spike-15\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>165&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523690\" data-ts=\"1575476292\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMC\" target=\"_blank\">AMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523690-wandas-zhang-reclaims-chairman-seat-amc\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wanda&#39;s Zhang reclaims chairman seat at AMC</a></h4><ul>   <li>Wanda Group's Lin Zhang is rejoining the board at AMC Entertainment (<a href=\"http://seekingalpha.com/symbol/AMC\" target=\"_blank\">AMC</a> <font color=\"red\">-1.9%</font>), unanimously elected to serve as <a href=\"https://seekingalpha.com/pr/17717320-lin-zhang-rejoins-amc-entertainment-holdings-inc-board-of-directors-non-executive-chairman\" target=\"_blank\">non-executive chairman</a>.</li>    <li>That's effective immediately. Zhang had been non-executive chairman from August 2012 to March 2018.</li>    <li>He's rejoining AMC in connection with recent new responsibilities overseeing all of Wanda's international investments.</li>    <li>He's replacing Zeng Maojun, who will remain on the board.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3523690\" data-linked=\"Wanda&#39;s Zhang reclaims chairman seat at AMC\" data-tweet=\"$AMC - Wanda&#39;s Zhang reclaims chairman seat at AMC https://seekingalpha.com/news/3523690-wandas-zhang-reclaims-chairman-seat-amc?source=tweet\" data-url=\"https://seekingalpha.com/news/3523690-wandas-zhang-reclaims-chairman-seat-amc\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>33&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523688\" data-ts=\"1575475516\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523688-healthcare-top-5-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers</a></h4><ul><li><b>Gainers: </b>Protagonist Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PTGX' title='Protagonist Therapeutics, Inc.'>PTGX</a>) <font color=\"green\">+53%</font>. Jounce Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/JNCE' title='Jounce Therapeutics, Inc.'>JNCE</a>) <font color=\"green\">+17%</font>. Kodiak Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/KOD' title='Kodiak Sciences Inc.'>KOD</a>) <font color=\"green\">+17%</font>. electroCore (NASDAQ:<a href='https://seekingalpha.com/symbol/ECOR' title='electroCore, Inc.'>ECOR</a>) <font color=\"green\">+16%</font>. Arbutus Biopharma (NASDAQ:<a href='https://seekingalpha.com/symbol/ABUS' title='Arbutus Biopharma Corporation'>ABUS</a>) <font color=\"green\">+13%</font>.</li><li><b>Losers: </b>Outlook Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/OTLK' title='Outlook Therapeutics, Inc.'>OTLK</a>) <font color=\"red\">-17%</font>. Revance Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/RVNC' title='Revance Therapeutics, Inc.'>RVNC</a>) <font color=\"red\">-16%</font>. Iterum Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ITRM' title='Iterum Therapeutics plc'>ITRM</a>) <font color=\"red\">-12%</font>. Oramed Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ORMP' title='Oramed Pharmaceuticals Inc.'>ORMP</a>) <font color=\"red\">-11%</font>. Atreca (NASDAQ:<a href='https://seekingalpha.com/symbol/BCEL' title='Atreca, Inc.'>BCEL</a>) <font color=\"red\">-10%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523688\" data-linked=\"Healthcare - Top 5 Gainers / Losers\" data-tweet=\"$PTGX $JNCE $KOD - Healthcare - Top 5 Gainers / Losers https://seekingalpha.com/news/3523688-healthcare-top-5-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3523688-healthcare-top-5-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523686\" data-ts=\"1575475105\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523686-capital-group-increases-stake-in-wynn-macau\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Capital Group increases stake in Wynn Macau</a></h4><ul> <li>Wynn Resorts (<a href='https://seekingalpha.com/symbol/WYNN' title='Wynn Resorts, Limited'>WYNN</a> <font color='green'>+1.9%</font>) is outperforming other stocks in the casino sector after The Capital Group Companies <a href=\"https://www.ggrasia.com/capital-group-spends-us21mln-to-up-stake-in-wynn-macau/\" target=\"_blank\">boosts</a> its stake in Wynn Macau (<a href='https://seekingalpha.com/symbol/WYNMF' title='Wynn Macau, Limited'>OTCPK:WYNMF</a>, <a href='https://seekingalpha.com/symbol/WYNMY' title='Wynn Macau, Limited'>OTCPK:WYNMY</a>) to 8.11% after acquiring another HKD166.5M worth of shares.</li> <li>The Capital Group is the second largest shareholder in Wynn Macau after majority owner Wynn Resorts.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3523686\" data-linked=\"Capital Group increases stake in Wynn Macau\" data-tweet=\"$WYNN $WYNMF $WYNMY - Capital Group increases stake in Wynn Macau https://seekingalpha.com/news/3523686-capital-group-increases-stake-in-wynn-macau?source=tweet\" data-url=\"https://seekingalpha.com/news/3523686-capital-group-increases-stake-in-wynn-macau\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523684\" data-ts=\"1575474335\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523684-investors-eye-jetblue-delta-intrigue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Investors eye JetBlue-Delta intrigue</a></h4><ul> <li>JetBlue (<a href='https://seekingalpha.com/symbol/JBLU' title='JetBlue Airways Corporation'>JBLU</a> <font color='green'>+3.2%</font>) trades higher amid some reports the company has backed out of a conference being hosted by Buckingham Research next week.</li> <li>What makes the development even more intriguing is that Delta Air Lines (<a href='https://seekingalpha.com/symbol/DAL' title='Delta Air Lines, Inc.'>DAL</a> <font color='green'>+1%</font>) is also said to have canceled.</li> <li>JetBlue has been the subject of merger chatter before without anything panning out.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3523684\" data-linked=\"Investors eye JetBlue-Delta intrigue\" data-tweet=\"$JBLU $DAL - Investors eye JetBlue-Delta intrigue https://seekingalpha.com/news/3523684-investors-eye-jetblue-delta-intrigue?source=tweet\" data-url=\"https://seekingalpha.com/news/3523684-investors-eye-jetblue-delta-intrigue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523677\" data-ts=\"1575473155\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523677-senior-housing-properties-trust-shareholders-to-receive-five-star-senior-living-share-payment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Senior Housing Properties Trust shareholders to receive Five Star Senior Living share payment dividend</a></h4><ul><li>As the part of the transaction agreement, Senior Housing Properties Trust (<a href='https://seekingalpha.com/symbol/SNH' title='Senior Housing Properties Trust'>SNH</a> <font color=\"green\">+1.4%</font>) expects that its each shareholder will receive pro rata distribution of ~0.07 common shares of Five Star Senior Living (<a href='https://seekingalpha.com/symbol/FVE' title='Five Star Senior Living Inc.'>FVE</a> <font color=\"red\">-1%</font>).</li><li>The Five Star Senior Living shares issuance will be on Jan. 1, 2020, subject to possible extension to Jan. 1, 2021, to holders on the record of Dec. 13, 2019.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3447647-five-star-senior-living-restructures-arrangements-senior-housing\" target=\"_blank\">Five Star Senior Living restructures arrangements with Senior Housing</a> (April 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3523677\" data-linked=\"Senior Housing Properties Trust shareholders to receive Five Star Senior Living share payment dividend\" data-tweet=\"$SNH $FVE - Senior Housing Properties Trust shareholders to receive Five Star Senior Living share payment dividend https://seekingalpha.com/news/3523677-senior-housing-properties-trust-shareholders-to-receive-five-star-senior-living-share-payment?source=tweet\" data-url=\"https://seekingalpha.com/news/3523677-senior-housing-properties-trust-shareholders-to-receive-five-star-senior-living-share-payment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523676\" data-ts=\"1575472994\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/USO\" target=\"_blank\">USO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523676-oil-prices-surge-ahead-of-opec-production-talks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oil prices surge ahead of OPEC production talks</a></h4><ul><li>Crude oil (<a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a> <font color='green'>+3.4%</font>) powers higher amid optimism that the OPEC+ group <a href=\"https://www.cnbc.com/2019/12/04/oil-markets-opec-meeting-in-focus.html\" target=\"_blank\">could approve deeper production cuts</a> when they meet in Vienna this week, with further support from industry data showing a <a href=\"https://seekingalpha.com/news/3523511-u-s-crude-supply-fell-3_7m-barrels-last-week-api-says\" target=\"_blank\">larger than forecast drop</a> in U.S. crude stockpiles.</li><li>January WTI <font color=\"green\">+3.7%</font> to $58.18/bbl; Brent <font color=\"green\">+3.4%</font> to $62.89/bbl.</li><li>\"A deeper cut is being preferred by a number of key members,\" Iraq oil minister Ghadhban told reporters in Vienna.</li><li>\"Amid trade war uncertainty, OPEC will be even more determined to maintain a floor on oil prices and will work to deliver precisely that outcome,\" surmises Stephen Innes, chief Asia market strategist at AxiTrader.</li><li>Meanwhile, OPEC's November crude exports excluding Iran reportedly <a href=\"https://www.bnnbloomberg.ca/opec-s-middle-east-oil-flows-shrink-as-group-mulls-extended-cuts-1.1357369\" target=\"_blank\">fell to their lowest level since July</a>, shipping an average of 14.79M bbl/day - 970K bbl/day below October levels and the lowest since July.</li><li>Among early gainers in the oil and gas sector: <a href='https://seekingalpha.com/symbol/DVN' title='Devon Energy Corporation'>DVN</a> <font color=\"green\">+4.5%</font>, <a href='https://seekingalpha.com/symbol/NBL' title='Noble Energy, Inc.'>NBL</a> <font color=\"green\">+4.4%</font>, <a href='https://seekingalpha.com/symbol/HAL' title='Halliburton Company'>HAL</a> <font color=\"green\">+3.9%</font>, <a href='https://seekingalpha.com/symbol/CXO' title='Concho Resources Inc.'>CXO</a> <font color=\"green\">+3.8%</font>, <a href='https://seekingalpha.com/symbol/PXD' title='Pioneer Natural Resources Company'>PXD</a> <font color=\"green\">+3.8%</font>, <a href='https://seekingalpha.com/symbol/CLR' title='Continental Resources, Inc.'>CLR</a> <font color=\"green\">+3.8%</font>, <a href='https://seekingalpha.com/symbol/EOG' title='EOG Resources, Inc.'>EOG</a> <font color=\"green\">+3.7%</font>, <a href='https://seekingalpha.com/symbol/MRO' title='Marathon Oil Corporation'>MRO</a> <font color=\"green\">+3.7%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P GSCI Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3x Long Crude Oil ETN'>UWT</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Trust II - ProShares Ultra Bloomberg Crude Oil'>UCO</a>, <a href='https://seekingalpha.com/symbol/XOP' title='SPDR S&P Oil & Gas Exploration & Production ETF'>XOP</a>, <a href='https://seekingalpha.com/symbol/VDE' title='Vanguard Energy ETF'>VDE</a>, <a href='https://seekingalpha.com/symbol/OIH' title='VanEck Vectors Oil Services ETF'>OIH</a>, <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>, <a href='https://seekingalpha.com/symbol/BNO' title='United States Brent Oil Fund, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/ERX' title='Direxion Daily Energy Bull 3x Shares ETF'>ERX</a>, <a href='https://seekingalpha.com/symbol/GUSH' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 3x Shares ETF'>GUSH</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BGR' title='BlackRock Energy&Resources Trust'>BGR</a>, <a href='https://seekingalpha.com/symbol/DRIP' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 3x Shares ETF'>DRIP</a>, <a href='https://seekingalpha.com/symbol/DBO' title='Invesco DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/ERY' title='Direxion Daily Energy Bear 3x Shares ETF'>ERY</a>, <a href='https://seekingalpha.com/symbol/FENY' title='Fidelity Covington Trust - Fidelity MSCI Energy Index ETF'>FENY</a>, <a href='https://seekingalpha.com/symbol/DIG' title='ProShares Ultra Oil & Gas ETF'>DIG</a>, <a href='https://seekingalpha.com/symbol/NDP' title='Tortoise Energy Independence Fund'>NDP</a>, <a href='https://seekingalpha.com/symbol/OILU' title='ProShares Trust II - ProShares UltraPro 3x Crude Oil ETF'>OILU</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/FIF' title='First Trust Energy Infrastructure Fund'>FIF</a>, <a href='https://seekingalpha.com/symbol/USL' title='United States 12 Month Oil Fund, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/IYE' title='iShares U.S. Energy ETF'>IYE</a>, <a href='https://seekingalpha.com/symbol/DUG' title='ProShares UltraShort Oil & Gas ETF'>DUG</a>, <a href='https://seekingalpha.com/symbol/IEO' title='iShares U.S. Oil & Gas Exploration & Production ETF'>IEO</a>, <a href='https://seekingalpha.com/symbol/USOU' title='USCF Funds Trust - United States 3x Oil Fund'>USOU</a>, <a href='https://seekingalpha.com/symbol/OILD' title='ProShares Trust II - ProShares UltraPro 3x Short Crude Oil ETF'>OILD</a>, <a href='https://seekingalpha.com/symbol/WTIU' title='ProShares Daily 3x Long Crude ETN'>WTIU</a>, <a href='https://seekingalpha.com/symbol/USOI' title='Credit Suisse Crude Oil Shares Covered Call ETN'>USOI</a>, <a href='https://seekingalpha.com/symbol/CRAK' title='VanEck Vectors Oil Refiners ETF'>CRAK</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3523676\" data-linked=\"Oil prices surge ahead of OPEC production talks\" data-tweet=\"$USO $DVN $NBL - Oil prices surge ahead of OPEC production talks https://seekingalpha.com/news/3523676-oil-prices-surge-ahead-of-opec-production-talks?source=tweet\" data-url=\"https://seekingalpha.com/news/3523676-oil-prices-surge-ahead-of-opec-production-talks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523675\" data-ts=\"1575472845\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STZ\" target=\"_blank\">STZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523675-constellation-brands-lauded-for-asset-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Constellation Brands lauded for asset sale</a></h4><ul> <li>It's pretty much a clean sweep of approvals from Wall Street on Constellation Brands' (<a href='https://seekingalpha.com/symbol/STZ' title='Constellation Brands, Inc.'>STZ</a> <font color=\"red\">-0.5%</font>) decision to <a href=\"https://seekingalpha.com/news/3523621-constellation-brands-unloads-ballast-point\" target=\"_blank\">unload</a> Ballast Point to focus on higher-margin categories.</li> <li>Cowen analyst Vivien Azer says the divestiture will allow Constellation to redeploy resources. \"Since taking over as CEO, Bill Newlands has established a clear mandate to focus on high growth, high margin brands to complement STZ's best-in-class import beer portfolio,\" she writes in a new note to investors. Cowen keeps Constellation locked in as its overall top pick.</li> <li>Credit Suisse, Evercore ISI and Jefferies are all out with similar notes that call the move a positive for the long term even if shares are bid down off the news.</li> <li>The <a href=\"https://seekingalpha.com/symbol/STZ/ratings/sell-side-ratings\" target=\"_blank\">average sell-side price target</a> on STZ implies 23% upside potential for shares.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3523675\" data-linked=\"Constellation Brands lauded for asset sale\" data-tweet=\"$STZ - Constellation Brands lauded for asset sale https://seekingalpha.com/news/3523675-constellation-brands-lauded-for-asset-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3523675-constellation-brands-lauded-for-asset-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>52&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523673\" data-ts=\"1575472624\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XXII\" target=\"_blank\">XXII</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523673-22nd-century-group-invests-in-panacea-life-sciences\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">22nd Century Group invests in Panacea Life Sciences</a></h4><ul><li>22nd Century Group (<a href='https://seekingalpha.com/symbol/XXII' title='22nd Century Group, Inc.'>XXII</a> <font color=\"green\">+2%</font>) <a href=\"https://seekingalpha.com/pr/17717369-22nd-century-group-enters-cbd-health-and-wellness-market-investment-in-panacea-life-sciences\" target=\"_blank\">closed</a> an investment in Panacea Life Sciences, a developer and producer of legal, THC-free, hemp-derived cannabinoid products.</li><li>22nd Century\u2019s investments in Panacea over the next 12 -18 months are expected to total $24M.</li><li>The company also received a warrant to purchase preferred stock of Panacea, which upon full exercise will provide 22nd Century with a controlling equity position in Panacea.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523673\" data-linked=\"22nd Century Group invests in Panacea Life Sciences\" data-tweet=\"$XXII - 22nd Century Group invests in Panacea Life Sciences https://seekingalpha.com/news/3523673-22nd-century-group-invests-in-panacea-life-sciences?source=tweet\" data-url=\"https://seekingalpha.com/news/3523673-22nd-century-group-invests-in-panacea-life-sciences\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523670\" data-ts=\"1575471806\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FTR\" target=\"_blank\">FTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523670-frontierplus-6_1-ceo-change-seen-positive-step\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Frontier +6.1% with CEO change seen as positive step</a></h4><ul>   <li>Frontier Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/FTR' title='Frontier Communications Corporation'>FTR</a>) is <font color=\"green\">up 6.1%</font> in first action after its change of the CEO guard, with recent Frontier financial adviser <a href=\"https://seekingalpha.com/news/3523499-frontier-ceo-mccarthy-exits\" target=\"_blank\">Bernie Han taking over for Daniel McCarthy</a>.</li>    <li>Cowen is reacting positively to the change, saying the shift is \"another logical step\" to a potential reorganization.</li>    <li>As creditors reportedly push for a debt reorg, Cowen's Gregory Williams expects Han would only take the job with some guarantees, such as a formalized plan.</li>    <li>And that would require buy-in: If an out-of-court unsecured swap happened, the company would need broad support for it to avoid bondholder/shareholder lawsuits.</li>    <li>He has a $1 price target, now implying 45% upside.</li>    <li>The take is much the same at Citi, though the firm is bearish despite the progress made with a new CEO. The company is a seller of shares and says Frontier needs to invest in full-fiber capabilities to keep up with competition - which may not be possible under the current capital structure.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3523670\" data-linked=\"Frontier +6.1% with CEO change seen as positive step\" data-tweet=\"$FTR - Frontier +6.1% with CEO change seen as positive step https://seekingalpha.com/news/3523670-frontierplus-6_1-ceo-change-seen-positive-step?source=tweet\" data-url=\"https://seekingalpha.com/news/3523670-frontierplus-6_1-ceo-change-seen-positive-step\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523667\" data-ts=\"1575471221\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523667-barnes-noble-educationminus-20-after-earnings-limp-in\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barnes &amp; Noble Education -20% after earnings limp in</a></h4><ul> <li>Barnes &amp; Noble Education (NYSE:<a href='https://seekingalpha.com/symbol/BNED' title='Barnes & Noble Education, Inc.'>BNED</a>) crumbles after missing estimates on both lines of its <a href=\"https://seekingalpha.com/news/3523627-barnes-and-amp-noble-education-eps-misses-0_21-misses-on-revenue\" target=\"_blank\">FQ2</a> report.</li> <li>Sales were down 5.2% during the quarter and adjusted EBITDA was reported at $74.5M vs. $82M consensus.</li> <li>The BNED board has engaged a financial advisor to assist in a review of strategic opportunities to accelerate the execution of customer-focused strategic initiatives and enhance value for shareholders. Options include continuing the execution of the company's current business plan, new partnerships, joint ventures and other potential opportunities.</li> <li>Shares of Barnes &amp; Noble are <font color=\"red\">down 20.31%</font> to trade at their lowest level since the middle part of October.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3523627-barnes-and-amp-noble-education-eps-misses-0_21-misses-on-revenue\" target=\"_blank\">Barnes &amp; Noble Education EPS misses by $0.21, misses on revenue</a> (Dec. 4)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3523667\" data-linked=\"Barnes &amp; Noble Education -20% after earnings limp in\" data-tweet=\"$BNED - Barnes &amp; Noble Education -20% after earnings limp in https://seekingalpha.com/news/3523667-barnes-noble-educationminus-20-after-earnings-limp-in?source=tweet\" data-url=\"https://seekingalpha.com/news/3523667-barnes-noble-educationminus-20-after-earnings-limp-in\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523663\" data-ts=\"1575470556\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EXPE\" target=\"_blank\">EXPE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523663-expediaplus-6-after-barry-diller-swoops-in\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Expedia +6% after Barry Diller swoops in</a></h4><ul> <li>Expedia (NASDAQ:<a href='https://seekingalpha.com/symbol/EXPE' title='Expedia Group, Inc.'>EXPE</a>) is flying higher in early trading after investors digest the major shakeup at the company and the hands-on approach of Barry Diller.</li> <li>The early word from analysts is that Diller's commitment to buy shares could provide a backstop to any downside.</li> <li>EXPE <font color=\"green\">+6.44%</font> to $107.05 vs. the 52-week trading range of $93.53 to $144.00.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3523644-major-shakeup-expedia\" target=\"_blank\">Major shakeup at Expedia</a> (Dec. 4)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3523663\" data-linked=\"Expedia +6% after Barry Diller swoops in\" data-tweet=\"$EXPE - Expedia +6% after Barry Diller swoops in https://seekingalpha.com/news/3523663-expediaplus-6-after-barry-diller-swoops-in?source=tweet\" data-url=\"https://seekingalpha.com/news/3523663-expediaplus-6-after-barry-diller-swoops-in\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523652\" data-ts=\"1575469255\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TMDX\" target=\"_blank\">TMDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523652-transmedics-up-3-premarket-on-positive-heart-system-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TransMedics up 3% premarket on positive heart system news</a></h4><ul><li>Thinly traded micro cap TransMedics Group (NASDAQ:<a href='https://seekingalpha.com/symbol/TMDX' title='TransMedics Group, Inc.'>TMDX</a>) perks up <font color=\"green\">3%</font> premarket on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/17717871-transmedics-organ-care-system-ocs-technology-used-in-first-u-s-adult-human-heart-transplants\" target=\"_blank\">announcement </a>of the first successful heart transplants from DCD (donation after circulatory death) donors in the U.S. enabled by its <a href=\"https://www.transmedics.com/ocs-heart/\" target=\"_blank\">OCS Heart System</a>.</li><li>The device is used to resuscitate the donor heart to a normal beating rate before transplantation (based on a clinical assessment at that time).</li><li>Heretofore, DCD donors are not considered viable transplant candidates due to the potential injury to the heart once beating ceases.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523652\" data-linked=\"TransMedics up 3% premarket on positive heart system news\" data-tweet=\"$TMDX - TransMedics up 3% premarket on positive heart system news https://seekingalpha.com/news/3523652-transmedics-up-3-premarket-on-positive-heart-system-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3523652-transmedics-up-3-premarket-on-positive-heart-system-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523644\" data-ts=\"1575468694\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EXPE\" target=\"_blank\">EXPE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523644-major-shakeup-expedia\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Major shakeup at Expedia</a></h4><ul> <li>Expedia Group (NASDAQ:<a href='https://seekingalpha.com/symbol/EXPE' title='Expedia Group, Inc.'>EXPE</a>) announces the resignation of CEO Mark Okerstrom and CFO Alan Pickerill, effective immediately.</li>                 <li>Chairman Barry Diller and Vice Chairman Peter Kern will oversee the company's executive leadership team, managing day-to-day operations, while the Board determines the long-term leadership of the company.</li>  <li>Chief Strategy Officer Eric Hart will serve as acting CFO.</li> <li>The company also announces a new share repurchase authorization for up to 20M million shares, which is on top of the 9M shares available under the current buyback plan.</li> <li>Barry Diller on the shakeup: \"Ultimately, senior management and the Board disagreed on strategy. Earlier this year, Expedia embarked on an ambitious reorganization plan with the goal of bringing our brands and technology together in a more efficient way. This reorganization, while sound in concept, resulted in a material loss of focus on our current operations, leading to disappointing third quarter results and a lackluster near-term outlook. The Board disagreed with that outlook, as well as the departing leadership's vision for growth, strongly believing the Company can accelerate growth in 2020.\"</li><li>Diller says he will be buying shares in Expedia as an indication of his confidence in the company's new path.</li> <li>EXPE  <font color=\"green\">+4.15%</font> premarket to  $103.50.</li>  <li>Source: <a href=\"https://seekingalpha.com/pr/17718032-expedia-group-announces-executive-leadership-changes\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3523644\" data-linked=\"Major shakeup at Expedia\" data-tweet=\"$EXPE - Major shakeup at Expedia https://seekingalpha.com/news/3523644-major-shakeup-expedia?source=tweet\" data-url=\"https://seekingalpha.com/news/3523644-major-shakeup-expedia\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523643\" data-ts=\"1575468689\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523643-gpro-clvs-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GPRO, CLVS among premarket gainers</a></h4><ul><li>Schmitt Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/SMIT' title='Schmitt Industries, Inc.'>SMIT</a>) <font color=\"green\">+13%</font> on $2M stock <a href=\"https://seekingalpha.com/pr/17717326-schmitt-industries-announces-2m-stock-repurchase-plan\" target=\"_blank\">repurchase plan</a>.</li><li>EyePoint Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/EYPT' title='EyePoint Pharmaceuticals, Inc.'>EYPT</a>) <font color=\"green\">+12%</font> on <a href=\"https://seekingalpha.com/news/3523586-eyepoint-up-12-premarket-on-expanded-access-of-dexycu\" target=\"_blank\">expanded access</a> of Dexycu.</li><li>Kodiak Sciences Inc. (NASDAQ:<a href='https://seekingalpha.com/symbol/KOD' title='Kodiak Sciences Inc.'>KOD</a>) <font color=\"green\">+11%</font> on <a href=\"https://seekingalpha.com/news/3523547-kodiak-sciences-prices-276m-equity-offering\" target=\"_blank\">pricing</a> of equity offering</li><li>Protagonist Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PTGX' title='Protagonist Therapeutics, Inc.'>PTGX</a>) <font color=\"green\">+10%</font> on <a href=\"https://seekingalpha.com/news/3523356-protagonist-down-26-on-interim-ptgminus-300-data-in-beta-thalassemia\" target=\"_blank\">interim PTG-300</a> data in beta thalassemia.</li><li>Option Care Health (NASDAQ:<a href='https://seekingalpha.com/symbol/BIOS' title='Option Care Health, Inc.'>BIOS</a>) <font color=\"green\">+9%</font>.</li><li>Lannett Company (NYSE:<a href='https://seekingalpha.com/symbol/LCI' title='Lannett Company, Inc.'>LCI</a>) <font color=\"green\">+9%</font> on <a href=\"https://seekingalpha.com/news/3523573-lannett-up-4-premarket-on-advancement-of-lantus-biosimilar\" target=\"_blank\">advancement</a> of Lantus biosimilar.</li><li>ASLAN Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ASLN' title='ASLAN Pharmaceuticals Limited'>ASLN</a>) <font color=\"green\">+9%</font>.</li><li>Omeros (NASDAQ:<a href='https://seekingalpha.com/symbol/OMER' title='Omeros Corporation'>OMER</a>) <font color=\"green\">+8%</font> as <a href=\"https://seekingalpha.com/news/3523589-omeros-narsoplimab-successful-in-pivotal-hsct-tma-study-shares-up-4-premarket\" target=\"_blank\">narsoplimab successful</a> in pivotal HSCT-TMA study.</li><li>Moleculin Biotech (NASDAQ:<a href='https://seekingalpha.com/symbol/MBRX' title='Moleculin Biotech, Inc.'>MBRX</a>) <font color=\"green\">+8%</font> on <a href=\"https://seekingalpha.com/pr/17717716-moleculin-announces-additional-positive-interim-results-from-phase-1-2-clinical-studies-of\" target=\"_blank\">announcing</a> additional positive interim results from phase 1/2 clinical studies of annamycin in acute myeloid leukemia.</li><li>Tata Motors (NYSE:<a href='https://seekingalpha.com/symbol/TTM' title='Tata Motors Limited'>TTM</a>) <font color=\"green\">+7%</font>.</li><li>Proteostasis Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PTI' title='Proteostasis Therapeutics, Inc.'>PTI</a>) <font color=\"green\">+6%</font>.</li><li>GoPro (NASDAQ:<a href='https://seekingalpha.com/symbol/GPRO' title='GoPro, Inc.'>GPRO</a>) <font color=\"green\">+5% </font>on <a href=\"https://seekingalpha.com/news/3523504-goproplus-2-on-strong-black-friday-sales\" target=\"_blank\">strong Black Friday sales</a>.</li><li>Clovis Oncology (NASDAQ:<a href='https://seekingalpha.com/symbol/CLVS' title='Clovis Oncology, Inc.'>CLVS</a>) <font color=\"green\">+6%</font>.</li><li>Cassava Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/SAVA' title='Cassava Sciences, Inc.'>SAVA</a>) <font color=\"green\">+5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523643\" data-linked=\"GPRO, CLVS among premarket gainers\" data-tweet=\"$SMIT $EYPT $KOD - GPRO, CLVS among premarket gainers https://seekingalpha.com/news/3523643-gpro-clvs-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3523643-gpro-clvs-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523642\" data-ts=\"1575468685\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523642-arwr-zs-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ARWR, ZS among premarket losers</a></h4><ul><li>Revance Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/RVNC' title='Revance Therapeutics, Inc.'>RVNC</a>) <font color=\"red\">-16%</font> on <a href=\"https://seekingalpha.com/news/3523614-revance-down-10-premarket-on-pricing-equity-offering\" target=\"_blank\">pricing</a> equity offering.</li><li>Outlook Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/OTLK' title='Outlook Therapeutics, Inc.'>OTLK</a>) <font color=\"red\">-10%</font>.</li><li>G-III Apparel Group (NASDAQ:<a href='https://seekingalpha.com/symbol/GIII' title='G-III Apparel Group, Ltd.'>GIII</a>) <font color=\"red\">-10%</font> on <a href=\"https://seekingalpha.com/news/3523576-g-iii-apparel-eps-beats-0_05-misses-on-revenue\" target=\"_blank\">Q3 earnings</a>.</li><li>Arrowhead Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ARWR' title='Arrowhead Pharmaceuticals, Inc.'>ARWR</a>) <font color=\"red\">-10%</font> on <a href=\"https://seekingalpha.com/news/3523555-arrowhead-down-8-premarket-on-pricing-equity-offering\" target=\"_blank\">pricing</a> equity offering.</li><li>Instructure (NYSE:<a href='https://seekingalpha.com/symbol/INST' title='Instructure, Inc.'>INST</a>) <font color=\"red\">-10%</font> after being <a href=\"https://seekingalpha.com/news/3523633-thoma-bravo-acquiring-instructure-in-2b-deal\" target=\"_blank\">acquired</a> by Thoma Bravo.</li><li>Cannae Holdings (NYSE:<a href='https://seekingalpha.com/symbol/CNNE' title='Cannae Holdings, Inc.'>CNNE</a>) <font color=\"red\">-7%</font> on <a href=\"https://seekingalpha.com/news/3523605-cannae-holdings-down-9-on-pricing-of-equity-offering\" target=\"_blank\">pricing</a> equity offering.</li><li>Zscaler (NASDAQ:<a href='https://seekingalpha.com/symbol/ZS' title='Zscaler, Inc.'>ZS</a>) <font color=\"red\">-5%</font> on <a href=\"https://seekingalpha.com/news/3523605-cannae-holdings-down-9-on-pricing-of-equity-offering\" target=\"_blank\">Q1 earnings</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3523642\" data-linked=\"ARWR, ZS among premarket losers\" data-tweet=\"$RVNC $OTLK $GIII - ARWR, ZS among premarket losers https://seekingalpha.com/news/3523642-arwr-zs-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3523642-arwr-zs-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523636\" data-ts=\"1575467983\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRPX\" target=\"_blank\">TRPX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523636-therapix-bio-prices-ads-offering-1_25-shares-up-2-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Therapix Bio prices ADS offering at $1.25; shares up 2% premarket</a></h4><ul><li>Thinly traded nano cap Therapix Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/TRPX' title='Therapix Biosciences Ltd.'>TRPX</a>) prices its <a href=\"https://seekingalpha.com/pr/17718010-therapix-biosciences-announces-pricing-of-1250-000-registered-direct-offering\" target=\"_blank\">direct offering</a> of 1M American Depositary Shares (ADSs) at $1.25 per ADS.</li><li>Gross proceeds should be $1.25M. Closing date is December 6.</li><li>Yesterday's close was $1.29.</li><li>Shares up <font color=\"green\">2%</font> premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523636\" data-linked=\"Therapix Bio prices ADS offering at $1.25; shares up 2% premarket\" data-tweet=\"$TRPX - Therapix Bio prices ADS offering at $1.25; shares up 2% premarket https://seekingalpha.com/news/3523636-therapix-bio-prices-ads-offering-1_25-shares-up-2-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3523636-therapix-bio-prices-ads-offering-1_25-shares-up-2-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523635\" data-ts=\"1575467828\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523635-icahn-presses-hp-to-continue-combination-talks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Icahn presses HP to continue combination talks</a></h4><ul><li>In a letter to HP (NYSE:<a href='https://seekingalpha.com/symbol/HPQ' title='HP Inc.'>HPQ</a>) shareholders, Carl Icahn says the company's standalone plans amount to \"little more than rearranging the deck chairs on the Titanic.\"</li><li>Icahn, in the letter viewed by <a href=\"https://www.bloomberg.com/news/articles/2019-12-03/icahn-urges-hp-to-move-forward-with-xerox-merger-discussions\" target=\"_blank\">Bloomberg</a>: \"It is absurd for the HP board and management team, with such a history of underperformance and missteps, to claim to have had a sudden epiphany and now expect shareholders to trust them to execute a standalone restructuring plan.\"</li><li>Icahn, who also owns a stake in Xerox (NYSE:<a href='https://seekingalpha.com/symbol/XRX' title='Xerox Holdings Corporation'>XRX</a>), wants the combination talks to continue and questions HP's board refusing XRX's proposal for mutual due diligence.</li><li>The activist investor owns a 4.2% stake in HP and a nearly 11% piece of Xerox, which makes him the largest XRX shareholder.</li><li>HP has previously agreed to one-way due diligence and said Xerox's $22/share offer undervalued the company.</li><li>HPQ is <font color=\"green\">up 0.8%</font> pre-market to $19.79.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523635\" data-linked=\"Icahn presses HP to continue combination talks\" data-tweet=\"$HPQ $XRX - Icahn presses HP to continue combination talks https://seekingalpha.com/news/3523635-icahn-presses-hp-to-continue-combination-talks?source=tweet\" data-url=\"https://seekingalpha.com/news/3523635-icahn-presses-hp-to-continue-combination-talks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523633\" data-ts=\"1575467185\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523633-thoma-bravo-acquiring-instructure-in-2b-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Thoma Bravo acquiring Instructure in $2B deal</a></h4><ul><li>Instructure (NYSE:<a href='https://seekingalpha.com/symbol/INST' title='Instructure, Inc.'>INST</a>) agrees to be acquired by PE firm Thoma Bravo for $47.60/share in cash.</li><li>The deal values INST at a $2B equity value.</li><li>The per share price represents an 18% premium to the three-month volume-weighted average price as of October 27, which was when the company announced the strategic review of its Bridge business.</li><li>CEO Dan Goldsmith and the current management team will continue to lead Instructure.</li><li>The agreement includes a 35-day go-shop period that expires on January 8.</li><li>INST shares are <font color=\"red\">down 9.4%</font> pre-market to $48.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523633\" data-linked=\"Thoma Bravo acquiring Instructure in $2B deal\" data-tweet=\"$INST - Thoma Bravo acquiring Instructure in $2B deal https://seekingalpha.com/news/3523633-thoma-bravo-acquiring-instructure-in-2b-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3523633-thoma-bravo-acquiring-instructure-in-2b-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523632\" data-ts=\"1575467163\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNSP\" target=\"_blank\">CNSP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523632-raymond-james-likes-zimmer-biomet-in-premarket-analyst-action\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Raymond James likes Zimmer Biomet in premarket analyst action</a></h4><ul><li>CNS Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CNSP' title='CNS Pharmaceuticals, Inc.'>CNSP</a>) initiated with Speculative Buy rating at Benchmark.</li><li>Proteostasis Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PTI' title='Proteostasis Therapeutics, Inc.'>PTI</a>) resumed with Overweight rating and $8 (203% upside) price target at Cantor Fitzgerald. Shares up <font color=\"green\">3%</font> premarket.</li><li>SpringWorks Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SWTX' title='SpringWorks Therapeutics, Inc.'>SWTX</a>) initiated with Buy rating and $33 (27% upside) price target at H.C. Wainwright.</li><li>STAAR Surgical Company (NASDAQ:<a href='https://seekingalpha.com/symbol/STAA' title='STAAR Surgical Company'>STAA</a>) initiated with Buy rating and $46 (25% upside) price target at BTIG Research.</li><li>Cidara Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/CDTX' title='Cidara Therapeutics, Inc.'>CDTX</a>) upgraded to Buy at WBB Securities.</li><li>Zimmer Biomet Holdings (NYSE:<a href='https://seekingalpha.com/symbol/ZBH' title='Zimmer Biomet Holdings, Inc.'>ZBH</a>) upgraded to Strong Buy with a $170 (19% upside) price target at Raymond James. Shares up <font color=\"green\">1%</font> premarket.</li><li>ViewRay (NASDAQ:<a href='https://seekingalpha.com/symbol/VRAY' title='ViewRay, Inc.'>VRAY</a>) downgraded to Neutral with a $199 price target at Compass Point. Shares down <font color=\"red\">6%</font> premarket in response to its equity offering.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523632\" data-linked=\"Raymond James likes Zimmer Biomet in premarket analyst action\" data-tweet=\"$CNSP $PTI $STAA - Raymond James likes Zimmer Biomet in premarket analyst action https://seekingalpha.com/news/3523632-raymond-james-likes-zimmer-biomet-in-premarket-analyst-action?source=tweet\" data-url=\"https://seekingalpha.com/news/3523632-raymond-james-likes-zimmer-biomet-in-premarket-analyst-action\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523629\" data-ts=\"1575466545\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVEO\" target=\"_blank\">AVEO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523629-aveo-down-7-premarket-on-positive-late-stage-tivozanib-data-in-kidney-cancer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aveo down 7% premarket on &quot;positive&quot; late-stage tivozanib data in kidney cancer</a></h4><ul><li>AVEO Oncology (NASDAQ:<a href='https://seekingalpha.com/symbol/AVEO' title='AVEO Pharmaceuticals, Inc.'>AVEO</a>) is down <font color=\"red\">7%</font> premarket on light volume in reaction to the <a href=\"https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045%2819%2930735-1/fulltext\" target=\"_blank\">publication </a>(<em>The Lancet Oncology</em>) of <a href=\"https://seekingalpha.com/pr/17717637-aveo-oncology-announces-lancet-oncology-publication-of-data-from-phase-3-tivominus-3-study-of\" target=\"_blank\">data</a> from a Phase 3 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02627963?lead=aveo+pharmaceuticals&amp;phase=2&amp;draw=2&amp;rank=1\" target=\"_blank\">TIVO-3</a>, comparing tivozanib to Bayer's (<a href='https://seekingalpha.com/symbol/BAYRY' title='Bayer Aktiengesellschaft'>OTCPK:BAYRY</a>) <a href=\"http://hcp.nexavar-us.com/?utm_source=google&amp;utm_medium=cpc&amp;utm_campaign=Nexavar-Generic_Branded_HCP_%3BS%3BPH%3BBR%3BONC%3BHCP%3BBR&amp;utm_content=Brand+Alone+++%7C+Exact&amp;utm_term=sorafenib&amp;matchtype=e&amp;device=c&amp;adposition=1t1&amp;loc=1014171&amp;gclid=Cj0KCQiAz53vBRCpARIsAPPsz8V_8By4rnvTtdyA5KDTIWnFh-5UYUWoZbEqd2skjDvS6tBq59ieBMoaAoYdEALw_wcB&amp;gclsrc=aw.ds\" target=\"_blank\">Nexavar</a> (sorafenib) in highly refractory metastatic renal cell carcinoma patients.</li><li>The study demonstrated tivozanib's superiority as measured by the primary endpoint of progression-free survival &#40;PFS&#41; and the secondary endpoint of overall response rate &#40;ORR&#41;, but not overall survival &#40;OS&#41;.</li><li>As of October 4, median progression-free survival &#40;PFS&#41; in the treatment group was 7.3 months compared to 5.1 months in the sorafenib group in a subpopulation of patients who received prior checkpoint inhibitor and VEGF TKI therapies. At year 1, PFS for tivozanib was 37% compared to 5% for sorafenib. At year 2, PFS for tivozanib was 28% versus 0% for sorafenib.</li><li>ORR was greater for tivozanib (18% vs. 8%, p=0.02) but OS, as of the August 15 cutoff, favored sorafenib (19.7 months vs. 16.4 months).</li><li>No new safety signals were observed. The most common tivozanib-related adverse event was hypertension (high blood pressure).</li></ul><div class=\"tiny-share-widget\" data-id=\"3523629\" data-linked=\"Aveo down 7% premarket on &quot;positive&quot; late-stage tivozanib data in kidney cancer\" data-tweet=\"$AVEO $BAYRY - Aveo down 7% premarket on &quot;positive&quot; late-stage tivozanib data in kidney cancer https://seekingalpha.com/news/3523629-aveo-down-7-premarket-on-positive-late-stage-tivozanib-data-in-kidney-cancer?source=tweet\" data-url=\"https://seekingalpha.com/news/3523629-aveo-down-7-premarket-on-positive-late-stage-tivozanib-data-in-kidney-cancer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523626\" data-ts=\"1575466191\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TGT\" target=\"_blank\">TGT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523626-cowen-sees-target-retail-winner\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cowen sees Target as retail winner</a></h4><ul> <li>Cowen <a href=\"https://www.cnbc.com/2019/12/04/cowen-names-target-a-best-idea-for-2020-says-digital-business-overcoming-amazon-threat.html\" target=\"_blank\">names</a> Target (<a href='https://seekingalpha.com/symbol/TGT' title='Target Corporation'>TGT</a>) as its \"best idea\" for 2020.</li> <li>\"We continue to foresee an environment of accelerating bifurcation in retail, with TGT well positioned as a long-term winner,\" says Cowen analyst Oliver Chen.</li><li>Chen also sees Target as better positioned from a valuation perspective to Walmart with shares trading at a significant multiple discount.</li> <li>While the Quant Rating and average sell-side rating on Target are bullish, the average <a href=\"https://seekingalpha.com/symbol/TGT/ratings/author-ratings#filter=all\" target=\"_blank\">Seeking Alpha author rating</a> is stuck at Neutral.</li><li>Shares of Target are <font color=\"green\">up 0.57%</font> premarket to $124.75.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3523626\" data-linked=\"Cowen sees Target as retail winner\" data-tweet=\"$TGT - Cowen sees Target as retail winner https://seekingalpha.com/news/3523626-cowen-sees-target-retail-winner?source=tweet\" data-url=\"https://seekingalpha.com/news/3523626-cowen-sees-target-retail-winner\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523625\" data-ts=\"1575465973\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNQ\" target=\"_blank\">CNQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523625-canadian-natural-resources-plans-c-250m-in-2020-spending\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canadian Natural Resources plans C$250M more in 2020 spending</a></h4><ul><li>Canadian Natural Resources (NYSE:<a href='https://seekingalpha.com/symbol/CNQ' title='Canadian Natural Resources Limited'>CNQ</a>) <font color=\"green\">+2.8%</font> pre-market after saying it <a href=\"https://seekingalpha.com/pr/17717551-canadian-natural-resources-limited-announces-2020-budget\" target=\"_blank\">plans a 2020 capital budget of $4.05B</a> with targeted production of 1.17M boe/day at mid-point of guidance, resulting in ~9% production per share growth.</li><li>Targeted 2020 volumes assume that the Alberta government curtailment program will continue throughout 2020, and as a result, anticipated production is 10K-25K bbl/day less  than it would have been without curtailments.</li><li>CNQ's planned C$4.05B capex is C$250M over 2019 levels, due to Alberta's recently announced elimination of curtailment for certain conventional drilling in Alberta and its previously announced reduction in income tax rates.</li><li>CNQ's targeted 2020 production of 1.14M-1.21M boe/day would be slightly higher than the 1.09M-1.15M boe/day it estimates for 2019.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523625\" data-linked=\"Canadian Natural Resources plans C$250M more in 2020 spending\" data-tweet=\"$CNQ - Canadian Natural Resources plans C$250M more in 2020 spending https://seekingalpha.com/news/3523625-canadian-natural-resources-plans-c-250m-in-2020-spending?source=tweet\" data-url=\"https://seekingalpha.com/news/3523625-canadian-natural-resources-plans-c-250m-in-2020-spending\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523624\" data-ts=\"1575465874\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WDAY\" target=\"_blank\">WDAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523624-workday-analysts-cautious-on-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Workday analysts cautious on outlook</a></h4><ul><li>Morgan Stanley (Equal-Weight, $180 price target) is \"enamored\" by Workday's (NASDAQ:<a href='https://seekingalpha.com/symbol/WDAY' title='Workday, Inc.'>WDAY</a>) large market opportunity, but sees yesterday's <a href=\"https://seekingalpha.com/news/3523506-workday-slides-during-call-guides-upside-q4\" target=\"_blank\">earnings results</a> validating the firm's valuation concerns.</li><li>The firm notes maturing HCM business \"weighed heavily on initial FY21 targets.\"</li><li>Canaccord Genuity (Buy, $200 PT) says WDAY has been \"both exhilarating and frustrating\" with \"clearly superior software\" that has taken longer than expected to scale up.</li><li>Canaccord notes the \"anxiety-inducing\" outlook but suspects and hopes that the FY21 view was at least mildly conservative.</li><li>Workday shares are <font color=\"red\">down 4.2%</font> pre-market to $166.28.</li><li>WDAY has a Bullish average <a href=\"https://seekingalpha.com/symbol/WDAY/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523624\" data-linked=\"Workday analysts cautious on outlook\" data-tweet=\"$WDAY - Workday analysts cautious on outlook https://seekingalpha.com/news/3523624-workday-analysts-cautious-on-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3523624-workday-analysts-cautious-on-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523623\" data-ts=\"1575465825\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RAPT\" target=\"_blank\">RAPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523623-new-finance-chief-rapt-therapeutics\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New finance chief at RAPT Therapeutics</a></h4><ul> <li>RAPT Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/RAPT' title='RAPT Therapeutics, Inc.'>RAPT</a>) <a href=\"https://seekingalpha.com/pr/17717861-rapt-therapeutics-appoints-rodney-young-chief-financial-officer\" target=\"_blank\">appoints</a> Rodney Young as Chief Financial Officer &#40;CFO&#41;, effective December 2, 2019.</li>   <li>Most recently, Mr. Young served as CFO of Cellerant Therapeutics, a private clinical-stage company developing cell and antibody-based immunotherapies for blood cancers and related disorders.</li><li>Shares are up <font color=\"green\">8%</font> premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3523623\" data-linked=\"New finance chief at RAPT Therapeutics\" data-tweet=\"$RAPT - New finance chief at RAPT Therapeutics https://seekingalpha.com/news/3523623-new-finance-chief-rapt-therapeutics?source=tweet\" data-url=\"https://seekingalpha.com/news/3523623-new-finance-chief-rapt-therapeutics\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523620\" data-ts=\"1575465346\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEEL\" target=\"_blank\">SEEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523620-seelos-nabs-u-s-patent-for-slsminus-005-shares-up-8-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seelos nabs U.S. patent for SLS-005; shares up 8% premarket</a></h4><ul> <li>Seelos Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SEEL' title='Seelos Therapeutics, Inc.'>SEEL</a>) is up <font color=\"green\">8%</font> premarket on <a href=\"https://seekingalpha.com/pr/17717754-seelos-therapeutics-receives-notice-of-allowance-for-additional-us-patent-for-trehalose\" target=\"_blank\">receiving</a> a Notice of Allowance from the USPTO for its Patent number 10,493,023 (Application number 14/889,727) titled: \u201cTreatment of Protein Aggregation Myopathic and Neurodegenerative Diseases by Pararental Adminstration of Trehalose\u201d (SLS-005).</li><li>Trehalose, a protein stabilizing sugar molecule, is being developed to treat oculopharyngeal muscular dystrophy.</li>       </ul><div class=\"tiny-share-widget\" data-id=\"3523620\" data-linked=\"Seelos nabs U.S. patent for SLS-005; shares up 8% premarket\" data-tweet=\"$SEEL - Seelos nabs U.S. patent for SLS-005; shares up 8% premarket https://seekingalpha.com/news/3523620-seelos-nabs-u-s-patent-for-slsminus-005-shares-up-8-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3523620-seelos-nabs-u-s-patent-for-slsminus-005-shares-up-8-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}